JP6426635B2 - Composition for alpha gel formation and alpha gel composition - Google Patents
Composition for alpha gel formation and alpha gel composition Download PDFInfo
- Publication number
- JP6426635B2 JP6426635B2 JP2016013181A JP2016013181A JP6426635B2 JP 6426635 B2 JP6426635 B2 JP 6426635B2 JP 2016013181 A JP2016013181 A JP 2016013181A JP 2016013181 A JP2016013181 A JP 2016013181A JP 6426635 B2 JP6426635 B2 JP 6426635B2
- Authority
- JP
- Japan
- Prior art keywords
- polyoxyethylene
- acid
- mass
- composition
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 39
- 230000015572 biosynthetic process Effects 0.000 title description 4
- -1 polyoxyethylene Polymers 0.000 claims description 157
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 92
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 239000002253 acid Substances 0.000 claims description 31
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 28
- 239000000194 fatty acid Substances 0.000 claims description 28
- 229930195729 fatty acid Natural products 0.000 claims description 28
- 150000004665 fatty acids Chemical class 0.000 claims description 19
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 11
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 229930182558 Sterol Natural products 0.000 claims description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 10
- 150000003904 phospholipids Chemical class 0.000 claims description 10
- 235000003702 sterols Nutrition 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 229940106189 ceramide Drugs 0.000 claims description 9
- 150000002148 esters Chemical class 0.000 claims description 9
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 9
- 150000003432 sterols Chemical class 0.000 claims description 9
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 8
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 8
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 8
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 8
- 150000003242 quaternary ammonium salts Chemical class 0.000 claims description 8
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 claims description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 7
- 235000010445 lecithin Nutrition 0.000 claims description 7
- 239000000787 lecithin Substances 0.000 claims description 7
- 229940067606 lecithin Drugs 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 235000012000 cholesterol Nutrition 0.000 claims description 5
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 claims description 2
- 239000000499 gel Substances 0.000 description 36
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 20
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 18
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- 239000000843 powder Substances 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 238000013329 compounding Methods 0.000 description 13
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 13
- 239000004166 Lanolin Substances 0.000 description 12
- 235000019388 lanolin Nutrition 0.000 description 12
- 229940039717 lanolin Drugs 0.000 description 12
- 229920001296 polysiloxane Polymers 0.000 description 12
- 239000004359 castor oil Substances 0.000 description 11
- 235000019438 castor oil Nutrition 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 11
- 229960000735 docosanol Drugs 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 10
- 239000001993 wax Substances 0.000 description 10
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 230000008020 evaporation Effects 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 235000015165 citric acid Nutrition 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- 239000002304 perfume Substances 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- DSSYKIVIOFKYAU-OIBJUYFYSA-N (S)-camphor Chemical compound C1C[C@]2(C)C(=O)C[C@H]1C2(C)C DSSYKIVIOFKYAU-OIBJUYFYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- JPPRXACMNPYJNK-UHFFFAOYSA-N 1-docosoxydocosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCCCCCC JPPRXACMNPYJNK-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 238000000333 X-ray scattering Methods 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- 229940056692 resinol Drugs 0.000 description 4
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 235000002020 sage Nutrition 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- 229920003169 water-soluble polymer Polymers 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ONTODYXHFBKCDK-UHFFFAOYSA-N 2-(2,4-dimethylphenyl)-1,3,5-triazine Chemical compound CC1=CC(C)=CC=C1C1=NC=NC=N1 ONTODYXHFBKCDK-UHFFFAOYSA-N 0.000 description 2
- TWUOURZWOOQWHI-UHFFFAOYSA-N 2-(2-oxononadecylamino)ethanesulfonic acid;sodium Chemical compound [Na].CCCCCCCCCCCCCCCCCC(=O)CNCCS(O)(=O)=O TWUOURZWOOQWHI-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229920006317 cationic polymer Polymers 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 239000002563 ionic surfactant Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- 239000012860 organic pigment Substances 0.000 description 2
- 229960000969 phenyl salicylate Drugs 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000003352 sequestering agent Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 2
- 229960000401 tranexamic acid Drugs 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- VQQFQUXKIKUEIU-DFWYDOINSA-N (2s)-5-oxopyrrolidine-2-carboxylic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)[C@@H]1CCC(=O)N1 VQQFQUXKIKUEIU-DFWYDOINSA-N 0.000 description 1
- RUHCWQAFCGVQJX-RVWHZBQESA-N (3s,8s,9s,10r,13r,14s,17r)-3-hydroxy-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-1-one Chemical compound C1C=C2C[C@H](O)CC(=O)[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 RUHCWQAFCGVQJX-RVWHZBQESA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- RECMXJOGNNTEBG-UHFFFAOYSA-N 1-phenylmethoxyethanol Chemical compound CC(O)OCC1=CC=CC=C1 RECMXJOGNNTEBG-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 1
- HVHARNWCHRYVII-UHFFFAOYSA-N 2,2-bis(hydroxymethyl)propane-1,3-diol;2-ethylhexanoic acid Chemical compound OCC(CO)(CO)CO.CCCCC(CC)C(O)=O HVHARNWCHRYVII-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- MXVBVDSNBADJOC-UHFFFAOYSA-N 2-(4,5-dihydroimidazol-1-yl)-4-hydroxybutanoic acid;sodium Chemical compound [Na].OCCC(C(O)=O)N1CCN=C1 MXVBVDSNBADJOC-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- AYUKNFXLSTVUAB-UHFFFAOYSA-N 2-[2-[2-(2,2-dimethylpropanoyloxy)propoxy]propoxy]propyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC(C)COC(C)COC(C)COC(=O)C(C)(C)C AYUKNFXLSTVUAB-UHFFFAOYSA-N 0.000 description 1
- LNCJHVLXANMHHD-UHFFFAOYSA-N 2-[2-heptadecyl-1-(2-hydroxyethyl)-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O LNCJHVLXANMHHD-UHFFFAOYSA-N 0.000 description 1
- GNCOVOVCHIHPHP-UHFFFAOYSA-N 2-[[4-[4-[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-3-chlorophenyl]-2-chlorophenyl]diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC(C(=C1)Cl)=CC=C1C(C=C1Cl)=CC=C1N=NC(C(C)=O)C(=O)NC1=CC=CC=C1 GNCOVOVCHIHPHP-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- WMNORUTYNGVDKW-UHFFFAOYSA-N 4-ethyl-2-[(4-methoxyphenyl)methylidene]octanoic acid;octyl 3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=C(OC)C=C1.CCCCC(CC)CC(C(O)=O)=CC1=CC=C(OC)C=C1 WMNORUTYNGVDKW-UHFFFAOYSA-N 0.000 description 1
- JOKBLKCZHGIRNO-UHFFFAOYSA-N 5-benzoyl-2-hydroxybenzoic acid Chemical compound C1=C(O)C(C(=O)O)=CC(C(=O)C=2C=CC=CC=2)=C1 JOKBLKCZHGIRNO-UHFFFAOYSA-N 0.000 description 1
- RDBLNMQDEWOUIB-UHFFFAOYSA-N 5-methyl-2-phenyl-1,3-benzoxazole Chemical compound N=1C2=CC(C)=CC=C2OC=1C1=CC=CC=C1 RDBLNMQDEWOUIB-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- GZVHEAJQGPRDLQ-UHFFFAOYSA-N 6-phenyl-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC(N)=NC(C=2C=CC=CC=2)=N1 GZVHEAJQGPRDLQ-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000283070 Equus zebra Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- HSRJKNPTNIJEKV-UHFFFAOYSA-N Guaifenesin Chemical compound COC1=CC=CC=C1OCC(O)CO HSRJKNPTNIJEKV-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 241000039951 Lithocarpus glaber Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 241000766653 Macrocephalon maleo Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- 229930182559 Natural dye Natural products 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052916 barium silicate Inorganic materials 0.000 description 1
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- WMNULTDOANGXRT-UHFFFAOYSA-N bis(2-ethylhexyl) butanedioate Chemical compound CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC WMNULTDOANGXRT-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- 229910000416 bismuth oxide Inorganic materials 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001055 blue pigment Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 239000001058 brown pigment Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229920003174 cellulose-based polymer Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- DERZBLKQOCDDDZ-JLHYYAGUSA-N cinnarizine Chemical compound C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)CCN1C\C=C\C1=CC=CC=C1 DERZBLKQOCDDDZ-JLHYYAGUSA-N 0.000 description 1
- 229960000876 cinnarizine Drugs 0.000 description 1
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- FGEUKKGODAGXOD-FMIVXFBMSA-N cyclohexyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound C1=CC(OC)=CC=C1\C=C\C(=O)OC1CCCCC1 FGEUKKGODAGXOD-FMIVXFBMSA-N 0.000 description 1
- TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 description 1
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- SILCDLWESNHZKB-UHFFFAOYSA-L disodium 4-hydroxy-4-oxobutanoate Chemical compound [Na+].[Na+].OC(=O)CCC([O-])=O.OC(=O)CCC([O-])=O SILCDLWESNHZKB-UHFFFAOYSA-L 0.000 description 1
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- BEKFZMITRGBPCF-UHFFFAOYSA-N ethene-1,1,2,2-tetrol Chemical group OC(O)=C(O)O BEKFZMITRGBPCF-UHFFFAOYSA-N 0.000 description 1
- KCDAMWRCUXGACP-DHZHZOJOSA-N ethyl (e)-2-cyano-3-phenylprop-2-enoate Chemical compound CCOC(=O)C(\C#N)=C\C1=CC=CC=C1 KCDAMWRCUXGACP-DHZHZOJOSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- XCRHYAQWBYDRGV-UHFFFAOYSA-N ethyl 3-(4-propan-2-ylphenyl)prop-2-enoate Chemical compound CCOC(=O)C=CC1=CC=C(C(C)C)C=C1 XCRHYAQWBYDRGV-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical class OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 239000001056 green pigment Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229940005740 hexametaphosphate Drugs 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- SJOXEWUZWQYCGL-DVOMOZLQSA-N menthyl salicylate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-DVOMOZLQSA-N 0.000 description 1
- 229960004665 menthyl salicylate Drugs 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- YKWKFUUHPFWRNV-UHFFFAOYSA-N methyl 3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound COC(=O)C=CC1=CC=C(C(C)C)C=C1C(C)C YKWKFUUHPFWRNV-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000000978 natural dye Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N nicotinic acid Natural products OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- LYXOWKPVTCPORE-UHFFFAOYSA-N phenyl-(4-phenylphenyl)methanone Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C(=O)C1=CC=CC=C1 LYXOWKPVTCPORE-UHFFFAOYSA-N 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- WZXKPNYMUZGZIA-RMKNXTFCSA-N propyl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound CCCOC(=O)\C=C\C1=CC=C(OC)C=C1 WZXKPNYMUZGZIA-RMKNXTFCSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- SJOXEWUZWQYCGL-UHFFFAOYSA-N salicylic acid menthyl ester Natural products CC(C)C1CCC(C)CC1OC(=O)C1=CC=CC=C1O SJOXEWUZWQYCGL-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- KMPHTYSTEHXSTL-UHFFFAOYSA-M sodium;2-hydroxypropanoate;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O.CC(O)C([O-])=O KMPHTYSTEHXSTL-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 229910052917 strontium silicate Inorganic materials 0.000 description 1
- QSQXISIULMTHLV-UHFFFAOYSA-N strontium;dioxido(oxo)silane Chemical compound [Sr+2].[O-][Si]([O-])=O QSQXISIULMTHLV-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- KWXLCDNSEHTOCB-UHFFFAOYSA-J tetrasodium;1,1-diphosphonatoethanol Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P(=O)([O-])C(O)(C)P([O-])([O-])=O KWXLCDNSEHTOCB-UHFFFAOYSA-J 0.000 description 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- SHWIJIJNPFXOFS-UHFFFAOYSA-N thiotaurine Chemical compound NCCS(O)(=O)=S SHWIJIJNPFXOFS-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- SVETUDAIEHYIKZ-IUPFWZBJSA-N tris[(z)-octadec-9-enyl] phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCCOP(=O)(OCCCCCCCC\C=C/CCCCCCCC)OCCCCCCCC\C=C/CCCCCCCC SVETUDAIEHYIKZ-IUPFWZBJSA-N 0.000 description 1
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- SOBHUZYZLFQYFK-UHFFFAOYSA-K trisodium;hydroxy-[[phosphonatomethyl(phosphonomethyl)amino]methyl]phosphinate Chemical compound [Na+].[Na+].[Na+].OP(O)(=O)CN(CP(O)([O-])=O)CP([O-])([O-])=O SOBHUZYZLFQYFK-UHFFFAOYSA-K 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
- 239000001052 yellow pigment Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229940105125 zinc myristate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GBFLQPIIIRJQLU-UHFFFAOYSA-L zinc;tetradecanoate Chemical compound [Zn+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O GBFLQPIIIRJQLU-UHFFFAOYSA-L 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/05—Alcohols; Metal alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/08—Stabilised against heat, light or radiation or oxydation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/54—Aqueous solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group
- C08L2205/025—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group containing two or more polymers of the same hierarchy C08L, and differing only in parameters such as density, comonomer content, molecular weight, structure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicinal Preparation (AREA)
Description
本発明はαゲル形成用組成物及びαゲル組成物、特にゲル形成物質の改良に関する。 The present invention relates to compositions for alpha gel formation and to improvements in alpha gel compositions, in particular gel formers.
従来より、化粧品、医薬部外品、医薬品などの皮膚外用剤の乳化安定性を保つ目的で、高級脂肪族アルコールや高級脂肪酸と親水性界面活性剤が形成するαゲルを用いたαゲル含有皮膚外用剤が用いられてきた。こうしたαゲルは、高い粘度で皮膚外用剤を安定にするが、塗布中ヌルヌルする感触があり、安定性的にも経時で高級アルコールや高級脂肪酸が結晶として析出しやすいなどの問題点があった(例えば、非特許文献1参照)。
また、経時で粘度が上昇する場合も多くみられ、2鎖型のカチオン界面活性剤などを粘度上昇防止剤として用いるようなことも検討されてきたが、充分良好な安定性は得られていなかった(例えば、非特許文献2参照)。更に、皮膚内部からの水分蒸散を防ぐ(オクル―ジョン)効果も充分ではなかった。
また、皮膚内部からの水分蒸散を防ぐ目的で、セラミド類、ジアルキル4級アンモニウム塩またはリン脂質などの2鎖型化合物とステロール類を含む同様の製剤(例えば、特許文献1)や、リン脂質、ポリオキシエチレンステロールエーテル類、高級アルコールを含む製剤(例えば、特許文献2、非特許文献3)が用いられてきたが、リン脂質類は着色や匂いなどの問題点があり、セラミドには結晶が析出しやすいといった問題点があった。
Conventionally, for the purpose of maintaining the emulsion stability of skin external preparations such as cosmetics, quasi-drugs, and pharmaceuticals, α-gel containing skin using α-gel formed of higher aliphatic alcohol and higher fatty acid and hydrophilic surfactant External preparations have been used. Such alpha gel stabilizes the external preparation for skin with high viscosity, but it has a feeling that it feels nully during application, and also has problems such as higher alcohol and higher fatty acid are easily precipitated as crystals over time. (For example, refer to nonpatent literature 1).
In addition, there are many cases where the viscosity increases with time, and it has been studied to use a two-chain type cationic surfactant or the like as a viscosity increase inhibitor, but a sufficiently good stability has not been obtained. (See, for example, Non-Patent Document 2). Furthermore, the effect of preventing water evaporation from the inside of the skin (occlusion) was not sufficient.
Furthermore, for the purpose of preventing water evaporation from the inside of the skin, similar preparations containing a two-chain type compound such as ceramides, dialkyl quaternary ammonium salts or phospholipids and sterols (for example, Patent Document 1), phospholipids, Preparations containing polyoxyethylene sterol ethers and higher alcohols (for example, Patent Document 2 and Non-patent Document 3) have been used, but phospholipids have problems such as coloring and odor, and crystals of ceramide have There was a problem that it was easy to precipitate out.
本発明は前記従来技術に鑑みなされたものであり、その解決すべき課題は、経時で着色、結晶析出などのない安定性の高いαゲル形成組成物及びそれを用いたαゲル組成物を提供することにある。
The present invention has been made in view of the above prior art, and the problem to be solved is to provide a highly stable α-gel forming composition free from coloring, crystal precipitation and the like with time and an α-gel composition using the same It is to do.
前記課題を解決するため、本発明者らが鋭意研究を重ねた結果、高級脂肪族アルコール及び/または高級脂肪酸、ポリオキシエチレンステロールエーテルと炭素数16以上の疎水基を2個有するポリオキシエチレンジアルキルエステル及び/またはエーテルを特定の割合で含むことにより、新規なαゲル組成物を形成することを見出し、本発明を完成するに至った。 In order to solve the above problems, as a result of intensive studies by the present inventors, higher aliphatic alcohol and / or higher fatty acid, polyoxyethylene sterol ether, and polyoxyethylene dialkyl having two or more hydrophobic groups having 16 or more carbon atoms It has been found that the formation of a novel α-gel composition by containing an ester and / or an ether in a specific ratio leads to the completion of the present invention.
すなわち、本発明にかかるαゲル形成用組成物は、
(A)1種または2種以上の炭素数16以上の高級脂肪族アルコール及び/または高級脂肪酸25〜50質量%
(B)下記一般式(I)で表されるポリオキシエチレンステロールエーテル40〜70質量%
(I)
(ただし、一般式IでRはコレステロール及び/またはフィトステロール残基、nは5〜20の整数を表わす。)
(C)下記一般式(II)で表されるポリオキシエチレンジアルキルエステル及び/またはエーテルを5〜20質量%
(II)
(ただし、一般式IIでR1及びR2は炭素数16〜24の直鎖脂肪族酸残基または直鎖脂肪族アルコール残基、nは4〜15の整数)
からなり、水相に添加されてゲルを形成することを特徴とする。
That is, the composition for forming α gel according to the present invention is
(A) 25 to 50 mass% of one or more higher aliphatic alcohol having 16 or more carbon atoms and / or higher fatty acid
(B) 40 to 70 mass% of polyoxyethylene sterol ether represented by the following general formula (I)
(I)
(However, in general formula I, R is a cholesterol and / or phytosterol residue, n is an integer of 5 to 20.)
(C) 5 to 20% by mass of polyoxyethylene dialkyl ester and / or ether represented by the following general formula (II)
(II)
(However, in the general formula II, R 1 and R 2 are linear aliphatic acid residues having 16 to 24 carbon atoms or linear aliphatic alcohol residues, and n is an integer of 4 to 15)
And is added to the aqueous phase to form a gel.
また、本発明にかかるαゲル組成物は、前記(A)〜(C)が水相中で形成したものであることを特徴とする。
また、上記のαゲル組成物に、窒素原子を有する2鎖型両親媒性物質をαゲル組成物中の有効分に対し0.1〜10質量%含有することが好適である。
また、前記ゲル組成物は、前記の窒素原子を有する2鎖型両親媒性物質がリン脂質、レシチン、リゾレシチン、セラミド、ジアルキル4級アンモニウム塩から選ばれる一種または二種以上からなることが好適である。
The α-gel composition according to the present invention is characterized in that the above (A) to (C) are formed in the aqueous phase.
In addition, it is preferable that the above-mentioned α-gel composition contains a 2-chain amphiphile having a nitrogen atom in an amount of 0.1 to 10% by mass based on the effective component in the α-gel composition.
In the gel composition, it is preferable that the two-chain amphiphilic substance having a nitrogen atom is one or more selected from phospholipid, lecithin, lysolecithin, ceramide and dialkyl quaternary ammonium salt. is there.
αゲル形成用組成物において、炭素数16以上の高級脂肪族アルコール及び/または高級脂肪酸の配合量は全有効分中25〜50質量%が好適である。炭素数16以上の高級脂肪族アルコールの例としては、セチルアルコール、セトステアリルアルコール、ステアリルアルコール、ベヘニルアルコール、バチルアルコールなどが挙げられる。高級脂肪酸の例としては、パルミチン酸、ステアリン酸、ベヘン酸などが挙げられる。
また、前記αゲル形成用組成物において、(I)のポリオキシエチレンステロールエーテルは、疎水基としてフィトステロール、コレステロール、エルゴステロールを有するものが好適であり、ポリオキシエチレン鎖は5〜30モルが好適である。例としては、ポリオキシエチレン(5モル)フィトステロール(例えば、日光ケミカルズ社製、Nikkol BPS-5)、ポリオキシエチレン(10モル)フィトステロール(例えば、日光ケミカルズ社製、Nikkol BPS-10)、ポリオキシエチレン(20モル)フィトステロール(例えば、日光ケミカルズ社製、Nikkol BPS-20)、ポリオキシエチレン(30モル)フィトステロール(例えば、日光ケミカルズ社製、Nikkol BPS-30)、ポリオキシエチレン(10モル)コレステロール(例えば、日本エマルジョン社製、Emalex CS-10)などが挙げられる。配合量としては全有効分中40〜70質量%が好適である。
In the composition for .alpha. gel formation, the blending amount of the higher aliphatic alcohol having 16 or more carbon atoms and / or the higher fatty acid is preferably 25 to 50% by mass in the total active ingredients. Examples of higher aliphatic alcohols having 16 or more carbon atoms include cetyl alcohol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, batyl alcohol and the like. Examples of higher fatty acids include palmitic acid, stearic acid, behenic acid and the like.
In the composition for forming α-gel, the polyoxyethylene sterol ether of (I) is preferably one having phytosterol, cholesterol, ergosterol as a hydrophobic group, and 5 to 30 moles of polyoxyethylene chain is preferable. It is. For example, polyoxyethylene (5 moles) phytosterol (eg, Nikko Chemicals BV, Nikkol BPS-5), polyoxyethylene (10 moles) Phytosterols (eg, Nikko Chemicals BV, Nikkol BPS-10), polyoxy acids Ethylene (20 moles) Phytosterol (eg, Nikko Chemicals BV-20), polyoxyethylene (30 moles) Phytosterol (eg P18 Nikkos BPS-30), polyoxyethylene (10 moles) cholesterol (For example, Emalex CS-10, manufactured by Nippon Emulsion Co., Ltd.) and the like. As a compounding quantity, 40-70 mass% is preferable in all the active ingredients.
前記αゲル形成用組成物において、(II)のポリオキシエチレンジアルキルエステル及び/またはエーテルは、炭素数16〜24の直鎖脂肪族酸残基または直鎖脂肪族アルコール残基を有するものが好適であり、ポリオキシエチレン鎖は4〜15モルが好適である。例としては、ポリオキシエチレン(4モル)ジステアリン酸(例えば、日本エマルジョン社製、Emalex 200DIS)、ポリオキシエチレン(6モル)ジステアリン酸(例えば、日本エマルジョン社製、Emalex 300DIS)、ポリオキシエチレン(8モル)ジステアリン酸(例えば、日本エマルジョン社製、Emalex 400DIS)、ポリオキシエチレン(12モル)ジステアリン酸(例えば、日本エマルジョン社製、Emalex 600DIS)、ステアリン酸ステアレス-4(例えば、日本エマルジョン社製、Emalex SWS-4)、ステアリン酸ステアレス-6(例えば、日本エマルジョン社製、Emalex SWS-6)、ステアリン酸ステアレス-9(例えば、日本エマルジョン社製、Emalex SWS-9)、ポリオキシエチレン(8モル)ジベヘニルエーテルなどが挙げられる。なお、ポリオキシエチレン鎖とアルキル基の結合様式はエステルでもエーテルでも、また、その両方が含まれても良い。配合量としては全有効分中5〜20質量%が好適である。 In the composition for forming α-gel, the polyoxyethylene dialkyl ester and / or ether of (II) is preferably one having a linear aliphatic acid residue or linear aliphatic alcohol residue having 16 to 24 carbon atoms The polyoxyethylene chain is preferably 4 to 15 moles. Examples include polyoxyethylene (4 moles) distearic acid (eg, Emalex 200 DIS, manufactured by Nippon Emulsion Co., Ltd.), polyoxyethylene (6 moles) distearic acid (eg, Emalex 300 DIS, manufactured by Nippon Emulsion Co., Ltd.), polyoxyethylene 8 moles) distearic acid (eg, Emalex 400 DIS, manufactured by Nippon Emulsion Co., Ltd.), polyoxyethylene (12 moles) distearic acid (eg, Emalex 600 DIS, manufactured by Nippon Emulsion Co., Ltd.), steareth 4 stearate (eg, manufactured by Nippon Emulsion Co., Ltd.) , Emalex SWS-4), Steareth Stearate-6 (eg, Emalex SWS-6, manufactured by Nippon Emulsion Co., Ltd.), Steareth Stearate-9 (eg, Emalex SWS-9, manufactured by Nippon Emulsion Co., Ltd.), polyoxyethylene (8 Mol) dibehenyl ether and the like. The mode of linkage of the polyoxyethylene chain and the alkyl group may be either ester or ether, or both. As a compounding quantity, 5-20 mass% is preferable in all the active ingredients.
リン脂質、レシチン、リゾレシチン、セラミド、ジアルキル4級アンモニウム塩などの窒素原子を有する2鎖型両親媒性物質の配合量は、αゲル組成物中の有効分に対し0.1〜10質量%が好適である。0.1質量%以下であると効果に乏しく、10質量%以上の配合では着色や結晶析出などの安定性上の問題が起こりやすい。
また、皮膚外用剤組成物中に前記αゲル組成物は任意の量を配合することができるが、一般的には皮膚外用剤中でαゲル組成物中の有効分として0.1〜20質量%が好適である。
The compounding amount of the two-chain amphiphilic substance having a nitrogen atom such as phospholipid, lecithin, lysolecithin, ceramide and dialkyl quaternary ammonium salt is 0.1 to 10% by mass with respect to the effective component in the α gel composition. It is suitable. If the content is 0.1% by mass or less, the effect is poor, and if it is 10% by mass or more, stability problems such as coloring and crystal precipitation easily occur.
In addition, although the above-mentioned α gel composition can be blended in any amount in the skin external preparation composition, it is generally 0.1 to 20 mass as an active ingredient in the α gel composition in the skin external preparation. % Is preferred.
本発明にかかるαゲル組成物及びそれを配合することを特徴とする皮膚外用剤組成物は、塗布中さっぱりとしていて、塗布後は皮膚内部からの水分蒸散を防ぐ(オクル―ジョン)効果が高く、リン脂質、レシチン、リゾレシチン、セラミド、ジアルキル4級アンモニウム塩などの窒素原子を有する2鎖型両親媒性物質を一緒に配合しても経時で着色、結晶析出などの安定性の問題が起こらない。
The α-gel composition according to the present invention and the external skin preparation composition characterized in that it is blended are refreshing during application, and after application, they are highly effective in preventing water evaporation from the inside of the skin (occlusion). Even if two chain type amphiphilic substances having nitrogen atoms such as phospholipid, lecithin, lysolecithin, ceramide and dialkyl quaternary ammonium salts are mixed together, stability problems such as coloring and crystal precipitation do not occur over time .
以下、本発明の構成について詳述する。
本発明にかかるαゲル組成物は、1種または2種以上の炭素数16以上の高級脂肪族アルコール及び/または高級脂肪酸25〜50質量%とポリオキシエチレンステロールエーテル40〜70質量%とポリオキシエチレンジアルキルエステル及び/またはエーテルを5〜20質量%を70〜80℃にて溶融させ、これに70〜80℃のイオン交換水を40〜90質量%の割合で加え撹拌後、冷却することにより得られる。また、1種または2種以上の炭素数16以上の高級脂肪族アルコール及び/または高級脂肪酸25〜50質量%とポリオキシエチレンステロールエーテル40〜70質量%とポリオキシエチレンジアルキルエステル及び/またはエーテルを5〜20質量%を70〜80℃にて溶融させた後、リン脂質、レシチン、リゾレシチン、セラミド、ジアルキル4級アンモニウム塩などの窒素原子を有する2鎖型両親媒性物質を加えて溶融させ、これに70〜80℃のイオン交換水を40〜90質量%の割合で加え撹拌後、冷却することにより得られる。なお、αゲルとは、一般には高級脂肪族アルコールと親水性界面活性剤が水中で形成する会合体であって、α構造(福島正二著「セチルアルコールの物理化学」フレグランスジャーナル社)をとるゲルを意味する。
Hereinafter, the configuration of the present invention will be described in detail.
The α-gel composition according to the present invention comprises one or more kinds of higher aliphatic alcohols having 16 or more carbon atoms and / or 25 to 50% by mass of higher fatty acids, 40 to 70% by mass of polyoxyethylene sterol ether, and polyoxy By dissolving 5 to 20% by mass of ethylene dialkyl ester and / or ether at 70 to 80 ° C., adding ion exchanged water of 70 to 80 ° C. at a ratio of 40 to 90% by mass, stirring and cooling can get. Also, one or two or more higher aliphatic alcohol having 16 or more carbon atoms and / or 25 to 50% by mass of higher fatty acid, 40 to 70% by mass of polyoxyethylene sterol ether, and polyoxyethylene dialkyl ester and / or ether After melting 5 to 20% by mass at 70 to 80 ° C., a 2-chain amphiphilic substance having a nitrogen atom such as phospholipid, lecithin, lysolecithin, ceramide or dialkyl quaternary ammonium salt is added and melted, It is obtained by adding and cooling ion-exchange water of 70-80 degreeC to this by the ratio of 40-90 mass%, and stirring. In addition, generally, an alpha gel is an aggregate formed by higher aliphatic alcohol and a hydrophilic surfactant in water, and is a gel having an alpha structure ("Physicochemistry of cetyl alcohol" Fragrances Journal, Inc. by Shoji Fukushima) Means
αゲル組成物の具体例として、1種または2種以上の炭素数16以上の高級脂肪族アルコール及び/または高級脂肪酸ステアリルアルコールを、ポリオキシエチレンステロールエーテルとして、ポリオキシエチレン(10モル)フィトステロール(例えば、日光ケミカルズ社製、Nikkol BPS-10)を、ポリオキシエチレンジアルキルエステル及び/またはエーテルとして、ポリオキシエチレン(6モル)ジステアリン酸(例えば、日本エマルジョン社製、Emalex 300DIS)を、それぞれ選定し、これらの混合物を70〜80℃にて一相にした後に全有効分量が全体の60質量%の割合になるように同温に加熱したイオン交換水を加えて、室温まで冷却して得た三成分系の相平衡図を図1に示した。図1で斜線部分は示差熱量分析計での融点ピークが1本でX線分析の結果、αゲルを示唆する散乱ピーク(図2)が得られた領域である。なお、図2は図1の★印で示す組成物のX線散乱スペクトルである。 As a specific example of the α gel composition, polyoxyethylene (10 moles) phytosterol (one or two or more kinds of higher aliphatic alcohol having 16 or more carbon atoms and / or higher fatty acid stearyl alcohol) as polyoxyethylene sterol ether For example, Nikkol BPS-10) manufactured by Nikko Chemicals Co., Ltd. is selected as polyoxyethylene dialkyl ester and / or ether, and polyoxyethylene (6 moles) distearic acid (for example, Emalex 300 DIS manufactured by Nippon Emulsion Co., Ltd.) is selected. These mixtures were brought into one phase at 70 to 80 ° C., and ion-exchanged water heated to the same temperature was added so that the total effective amount became 60% by mass of the whole, and cooled to room temperature. The phase equilibrium diagram of the ternary system is shown in FIG. The hatched area in FIG. 1 is a region where a scattering peak (FIG. 2) indicating α gel is obtained as a result of X-ray analysis with a single melting point peak in a differential thermal analyzer. In addition, FIG. 2 is an X-ray scattering spectrum of the composition shown by * mark of FIG.
また、ステアリルアルコールをステアリン酸に変えても、同様にαゲルを示唆するX線散乱スペクトルが得られた(図3)。図1から明らかなようにステアリルアルコール25〜50質量%、ポリオキシエチレン(10モル)フィトステロール40〜70質量%、ポリオキシエチレン(6モル)ジステアリン酸5〜20質量%の領域でαゲルになることが確認された。
本発明では、上記3成分のみでαゲルを構築できるが、肌荒れ改善などの目的で必要に応じて、リン脂質、レシチン、リゾレシチン、セラミド、ジアルキル4級アンモニウム塩などの窒素原子を有する2鎖型両親媒性物質を併せて配合することもできる。
Also, even when stearyl alcohol was changed to stearic acid, an X-ray scattering spectrum was obtained that also suggested α gel (FIG. 3). As apparent from FIG. 1, α gel is formed in the region of 25 to 50% by mass of stearyl alcohol, 40 to 70% by mass of polyoxyethylene (10 mol) phytosterol, and 5 to 20% by mass of polyoxyethylene (6 mol) distearic acid That was confirmed.
In the present invention, an α-gel can be constructed using only the above three components, but if necessary for the purpose of improving skin roughness etc., a two-chain type having a nitrogen atom such as phospholipid, lecithin, lysolecithin, ceramide, dialkyl quaternary ammonium salt, etc. Amphiphilic substances can also be blended together.
本発明の皮膚外用剤に用いられる油分は、特に限定されるものではなく、例えば、液体油脂、固体油脂、ロウ類、炭化水素油、高級脂肪酸、合成エステル油、シリコーン油などを適宜配合でき、更に、一部の高級アルコールを前期油分に溶解して乳化することもできる。目的のαゲル含有皮膚外用剤に対する配合量としては特に限定しないが、0.05〜50質量%が好ましい。0.05質量%以下の場合は皮膚外用剤としての効果に乏しく、50質量%を超えると使用感触が悪くなる。 The oil component used for the external preparation for skin of the present invention is not particularly limited, and, for example, liquid oil and fat, solid oil and fat, waxes, hydrocarbon oil, higher fatty acid, synthetic ester oil, silicone oil and the like can be appropriately blended. Furthermore, it is also possible to dissolve and emulsify some higher alcohol in the above-mentioned oil. Although it does not specifically limit as a compounding quantity with respect to the objective alpha gel containing skin external preparation, 0.05-50 mass% is preferable. If the amount is less than 0.05% by mass, the effect as an external preparation for the skin is poor, and if it exceeds 50% by mass, the use feeling becomes worse.
液体油脂としては、例えば、アボガド油、ツバキ油、タートル油、マカデミアナッツ油、トウモロコシ油、ミンク油、オリーブ油、ナタネ油、卵黄油、ゴマ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、胚芽油、トリグリセリン等が挙げられる。
固体油脂としては、例えば、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、モクロウ、硬化ヒマシ油等が挙げられる。
ロウ類としては、例えば、ミツロウ、カンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、ラノリン、カポックロウ、酢酸ラノリン、液状ラノリン、サトウキビロウ、ラノリン脂肪酸イソプロピル、ラウリン酸ヘキシル、還元ラノリン、ジョジョバロウ、硬質ラノリン、セラックロウ、ポリオキシエチレンラノリンアルコールエーテル、ポリオキシエチレンラノリンアルコールアセテート、ポリオキシエチレンコレステロールエーテル、ラノリン脂肪酸ポリエチレングリコール、 ポリオキシエチレン水素添加ラノリンアルコールエーテル、パルミチン酸セチルらが挙げられる。
炭化水素油としては、例えば、流動パラフィン、オゾケライト、スクワラン、プリスタン、パラフィン、セレシン、スクワレン、ワセリン、マイクロクリスタリンワックス等が挙げられる。
Examples of liquid oils and fats include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil And safflower oil, cottonseed oil, eno oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, Japanese oak oil, Japanese tung oil, jojoba oil, germ oil, triglycerin and the like.
As solid fats and oils, for example, cacao butter, coconut oil, horse fat, hydrogenated coconut oil, palm oil, beef tallow, sheep fat, hydrogenated beef tallow, palm kernel oil, pork fat, beef bone fat, mokurou kernel oil, hydrogenated oil, beef Examples include foot fat, wax wax, hydrogenated castor oil and the like.
Examples of the waxes include beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, ivory wax, persimmon wax, montan wax, nuka wax, lanolin, kapok wax, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, reduced lanolin , Jojoba wax, hard lanolin, shellac wax, polyoxyethylene lanolin alcohol ether, polyoxyethylene lanolin alcohol acetate, polyoxyethylene cholesterol ether, lanolin fatty acid polyethylene glycol, polyoxyethylene hydrogenated lanolin alcohol ether, cetyl palmitate, etc. .
Examples of hydrocarbon oils include liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalene, vaseline, microcrystalline wax and the like.
高級脂肪酸としては、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、オレイン酸、ウンデシレン酸、トール酸、イソステアリン酸、リノール酸、リノレイン酸、エイコサペンタエン酸(EPA)、ドコサヘキサエン酸(DHA)等が挙げられる。
合成エステル油としては、例えば、オクタン酸セチル、ミリスチン酸ミリスチル、トリ2−エチルヘキサン酸グリセリル、テトラ2−エチルヘキサン酸ペンタエリトリット、コハク酸ジオクチル、ジネオペンタン酸トリプロピレングリコール等が挙げられる。
シリコーン油としては、例えば、鎖状ポリシロキサン(例えば、ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等);環状ポリシロキサン(例えば、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等)、3次元網目構造を形成しているシリコーン樹脂、シリコーンゴム、各種変性ポリシロキサン(アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等)、アクリルシリコーン類等が挙げられる。
Examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tallic acid, isostearic acid, linoleic acid, linoleic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid ( DHA) and the like.
Examples of synthetic ester oils include cetyl octanoate, myristyl myristate, glyceryl tri-2-ethylhexanoate, pentaerythritol tetra2-ethylhexanoate, dioctyl succinate, tripropylene glycol dineopentanoate, and the like.
As silicone oil, for example, linear polysiloxane (for example, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane and the like); cyclic polysiloxane (for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexene) Silicone resin, silicone rubber, various modified polysiloxanes (amino modified polysiloxane, polyether modified polysiloxane, alkyl modified polysiloxane, fluorine modified polysiloxane etc.), acrylic silicone And the like.
本発明にかかるαゲル含有皮膚外用剤は、例えば、皮膚、頭髪など身体に適用し得る、皮膚化粧料、頭髪洗浄料、皮膚洗浄料、整髪料等に用いることができる。
また、本発明にかかるαゲル含有皮膚外用剤には、上記必須成分の他に、通常、化粧品、医薬品等に用いられる成分を安定性に影響が出ない範囲の配合量で配合することができる。かかる成分としては、例えば、粉末成分、両性界面活性剤、イオン性界面活性剤、非イオン界面活性剤、保湿剤、増粘剤、皮膜剤、紫外線吸収剤、金属イオン封鎖剤、pH調整剤、皮膚栄養剤、ビタミン、酸化防止剤、酸化防止助剤、香料等が挙げられる。
The α-gel-containing external skin preparation according to the present invention can be used, for example, in skin cosmetics, hair cleansing agents, skin cleansing agents, hair styling agents, etc. that can be applied to the body such as skin and hair.
In addition to the above-mentioned essential components, components for use in cosmetics, medicines, etc. can be added to the alpha gel-containing external skin preparation according to the present invention in such amounts that do not affect the stability. . Such components include, for example, powder components, amphoteric surfactants, ionic surfactants, nonionic surfactants, moisturizers, thickeners, film agents, UV absorbers, sequestering agents, pH adjusters, Skin nutrients, vitamins, antioxidants, antioxidant aids, perfumes, etc. may be mentioned.
粉末成分としては、例えば、無機粉末(例えば、タルク、カオリン、雲母、絹雲母(セリサイト)、白雲母、金雲母、合成雲母、紅雲母、黒雲母、バーミキュライト、ベントナイト、ヘクトライト、ラポナイト、炭酸マグネシウム、炭酸カルシウム、ケイ酸アルミニウム、ケイ酸バリウム、ケイ酸カルシウム、ケイ酸マグネシウム、ケイ酸ストロンチウム、タングステン酸金属塩、マグネシウム、シリカ、ゼオライト、硫酸バリウム、焼成硫酸カルシウム(焼セッコウ)、リン酸カルシウム、弗素アパタイト、ヒドロキシアパタイト、セラミックパウダー、金属石鹸(例えば、ミリスチン酸亜鉛、パルミチン酸カルシウム、ステアリン酸アルミニウム)、窒化ホウ素等);有機粉末(例えば、ポリアミド樹脂粉末(ナイロン粉末)、ポリエチレン粉末、ポリメタクリル酸メチル粉末、ポリスチレン粉末、スチレンとアクリル酸の共重合体樹脂粉末、ベンゾグアナミン樹脂粉末、ポリ四弗化エチレン粉末、セルロース粉末等);無機白色顔料(例えば、二酸化チタン、酸化亜鉛等);無機赤色系顔料(例えば、酸化鉄(ベンガラ)、チタン酸鉄等);無機褐色系顔料(例えば、γ−酸化鉄等);無機黄色系顔料(例えば、黄酸化鉄、黄土等);無機黒色系顔料(例えば、黒酸化鉄、低次酸化チタン等);無機紫色系顔料(例えば、マンゴバイオレット、コバルトバイオレット等);無機緑色系顔料(例えば、酸化クロム、水酸化クロム、チタン酸コバルト等);無機青色系顔料(例えば、群青、紺青等);パール顔料(例えば、酸化チタンコーテッドマイカ、酸化チタンコーテッドオキシ塩化ビスマス、酸化チタンコーテッドタルク、着色酸化チタンコーテッドマイカ、オキシ塩化ビスマス、魚鱗箔等);金属粉末顔料(例えば、アルミニウムパウダー、カッパーパウダー等);ジルコニウム、バリウム又はアルミニウムレーキ等の有機顔料(例えば、赤色201号、赤色202号、赤色204号、赤色205号、赤色220号、赤色226号、赤色228号、赤色405号、橙色203号、橙色204号、黄色205号、黄色401号、及び青色404号などの有機顔料、赤色3号、赤色104号、赤色106号、赤色227号、赤色230号、赤色401号、赤色505号、橙色205号、黄色4号、黄色5号、黄色202号、黄色203号、緑色3号及び青色1号等);天然色素(例えば、クロロフィル、β−カロチン等)等が挙げられる。 As a powder component, for example, inorganic powder (for example, talc, kaolin, mica, sericite (sericite), muscovite, phlogopite, synthetic mica, pyromica, biotite, vermiculite, bentonite, hectorite, laponite, carbonate Magnesium, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, tungstate metal salt, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate (gypsum gypsum), calcium phosphate, fluorine Apatite, hydroxyapatite, ceramic powder, metal soap (eg, zinc myristate, calcium palmitate, aluminum stearate), boron nitride, etc .; organic powder (eg, polyamide resin powder (nylon powder), polyethylene powder, Methyl polymethacrylate powder, polystyrene powder, copolymer resin powder of styrene and acrylic acid, benzoguanamine resin powder, polytetrafluoroethylene powder, cellulose powder, etc .; Inorganic white pigment (eg, titanium dioxide, zinc oxide etc.); Inorganic red pigments (eg iron oxide (iron), iron titanate etc.); inorganic brown pigments (eg γ-iron oxide etc); inorganic yellow pigments (eg yellow iron oxide, yellow earth etc); inorganic black Based pigments (for example, black iron oxide, lower order titanium oxide, etc.); Inorganic purple pigments (for example, mango violet, cobalt violet etc.); Inorganic green pigments (eg, chromium oxide, chromium hydroxide, cobalt titanate etc.) Inorganic blue pigments (eg, ultramarine blue, bituminous, etc.); pearl pigments (eg, titanium oxide coated mica, titanium oxide coated oxy oxychloride bismuth oxide) Titanium oxide coated talc, colored titanium oxide coated mica, bismuth oxychloride, fish scale foil, etc .; metal powder pigments (eg, aluminum powder, kappa powder etc.); organic pigments such as zirconium, barium or aluminum lake (eg, red 201) , Red 202, Red 204, Red 205, Red 220, Red 226, Red 228, Red 405, Orange 203, Orange 204, Yellow 205, Yellow 401, and Blue 404 And other organic pigments, Red No. 3, Red No. 104, Red No. 106, Red No. 227, Red No. 230, Red No. 401, Red No. 505, Orange No. 205, Yellow No. 4, Yellow No. 5, Yellow No. 202, Yellow No. 202 No. 203, Green No. 3 and Blue No. 1); Natural dyes (eg, chlorophyll, β-carotene etc.), etc. That.
両性界面活性剤としては、例えば、イミダゾリン系両性界面活性剤(例えば、2-ウンデシル-N,N,N-(ヒドロキシエチルカルボキシメチル)-2-イミダゾリンナトリウム、2-ココイル-2-イミダゾリニウムヒドロキサイド-1-カルボキシエチロキシ2ナトリウム塩等);ベタイン系界面活性剤(例えば、2-ヘプタデシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン、ラウリルジメチルアミノ酢酸ベタイン、アルキルベタイン、アミドベタイン、スルホベタイン等)等が挙げられる。
イオン性界面活性剤としては、N-アシルメチルタウリン塩、N-アシルグルタミン酸塩、アルキル硫酸塩、ポリオキシエチレンアルキル硫酸塩、脂肪酸石鹸、アルキル4級アンモニウム塩などが挙げられる。
Examples of amphoteric surfactants include imidazoline amphoteric surfactants (eg, 2-undecyl-N, N, N- (hydroxyethylcarboxymethyl) -2-imidazoline sodium, 2-cocoyl-2-imidazolinium hydroxide). Side-1-carboxyethyloxy disodium salt and the like); betaine surfactants (eg, 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryl dimethylaminoacetic acid betaine, alkyl betaine, amido betaine) And sulfobetaine etc.).
Examples of the ionic surfactant include N-acylmethyl taurine salts, N-acyl glutamates, alkyl sulfates, polyoxyethylene alkyl sulfates, fatty acid soaps, alkyl quaternary ammonium salts and the like.
親油性非イオン界面活性剤としては、例えば、ソルビタン脂肪酸エステル類(例えば、ソルビタンモノオレエート、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ソルビタンセスキオレエート、ソルビタントリオレエート、ペンタ-2-エチルヘキシル酸ジグリセロールソルビタン、テトラ-2-エチルヘキシル酸ジグリセロールソルビタン等);グリセリンポリグリセリン脂肪酸類(例えば、モノ綿実油脂肪酸グリセリン、モノエルカ酸グリセリン、セスキオレイン酸グリセリン、モノステアリン酸グリセリン、α,α'-オレイン酸ピログルタミン酸グリセリン、モノステアリン酸グリセリンリンゴ酸等);プロピレングリコール脂肪酸エステル類(例えば、モノステアリン酸プロピレングリコール等);硬化ヒマシ油誘導体;グリセリンアルキルエーテル等が挙げられる。 Examples of lipophilic nonionic surfactants include sorbitan fatty acid esters (eg, sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan monopalmitate, sorbitan monostearate, sorbitan sesquioleate, Sorbitan trioleate, diglycerol sorbitan penta-2-ethylhexyl acid, diglycerol sorbitan tetra-2-ethylhexyl acid, etc. Glycerin polyglycerin fatty acids (eg mono cotton seed oil fatty acid glycerin, monoerlucate glycerin, sesquioleic acid glycerin, monostearin Acid glycerin, α, α'-oleic acid pyroglutamic acid glycerin, monostearic acid glycerin malic acid, etc .; propylene glycol fatty acid esters (eg, monostearic acid) Acid propylene glycol and the like); hardened castor oil derivatives; glycerin alkyl ether and the like.
親水性非イオン界面活性剤としては、例えば、ポリオキシエチレンソルビタン脂肪酸エステル類(例えば、ポリオキシエチレンソルビタンモノオレエート、ポリオキシエチレンソルビタンモノステアレート、ポリオキシエチレンソルビタンモノオレエート、ポリオキシエチレンソルビタンテトラオレエート等);ポリオキシエチレンソルビット脂肪酸エステル類(例えば、ポリオキシエチレンソルビットモノラウレート、ポリオキシエチレンソルビットモノオレエート、ポリオキシエチレンソルビットペンタオレエート、ポリオキシエチレンソルビットモノステアレート等);ポリオキシエチレングリセリン脂肪酸エステル類(例えば、ポリオキシエチレングリセリンモノステアレート、ポリオキシエチレングリセリンモノイソステアレート、ポリオキシエチレングリセリントリイソステアレート等のポリオキシエチレンモノオレエート等);ポリオキシエチレン脂肪酸エステル類(例えば、ポリオキシエチレンジステアレート、ポリオキシエチレンモノジオレエート、ジステアリン酸エチレングリコール等);ポリオキシエチレンアルキルエーテル類(例えば、ポリオキシエチレンラウリルエーテル、ポリオキシエチレンオレイルエーテル、ポリオキシエチレンステアリルエーテル、ポリオキシエチレンベヘニルエーテル、ポリオキシエチレン2-オクチルドデシルエーテル、ポリオキシエチレンコレスタノールエーテル等);プルロニック型類(例えば、プルロニック等);ポリオキシエチレン・ポリオキシプロピレンアルキルエーテル類(例えば、ポリオキシエチレン・ポリオキシプロピレンセチルエーテル、ポリオキシエチレン・ポリオキシプロピレン2-デシルテトラデシルエーテル、ポリオキシエチレン・ポリオキシプロピレンモノブチルエーテル、ポリオキシエチレン・ポリオキシプロピレン水添ラノリン、ポリオキシエチレン・ポリオキシプロピレングリセリンエーテル等);テトラ ポリオキシエチレン・テトラポリオキシプロピレンエチレンジアミン縮合物類(例えば、テトロニック等);ポリオキシエチレンヒマシ油硬化ヒマシ油誘導体(例えば、ポリオキシエチレンヒマシ油、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレン硬化ヒマシ油モノイソステアレート、ポリオキシエチレン硬化ヒマシ油トリイソステアレート、ポリオキシエチレン硬化ヒマシ油モノピログルタミン酸モノイソステアリン酸ジエステル、ポリオキシエチレン硬化ヒマシ油マレイン酸等);ポリオキシエチレンミツロウ・ラノリン誘導体(例えば、ポリオキシエチレンソルビットミツロウ等);アルカノールアミド(例えば、ヤシ油脂肪酸ジエタノールアミド、ラウリン酸モノエタノールアミド、脂肪酸イソプロパノールアミド等);ポリオキシエチレンプロピレングリコール脂肪酸エステル;ポリオキシエチレンアルキルアミン;ポリオキシエチレン脂肪酸アミド;ショ糖脂肪酸エステル;アルキルエトキシジメチルアミンオキシド;トリオレイルリン酸等が挙げられる。 As a hydrophilic nonionic surfactant, for example, polyoxyethylene sorbitan fatty acid esters (eg, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan Tetraoleate etc.); polyoxyethylene sorbite fatty acid esters (eg, polyoxyethylene sorbite monolaurate, polyoxyethylene sorbite monooleate, polyoxyethylene sorbite pentaoleate, polyoxyethylene sorbite monostearate etc); Polyoxyethylene glycerin fatty acid esters (eg, polyoxyethylene glycerin monostearate, polyoxyethylene glycerin monoisostearate Polyoxyethylene monooleate such as polyoxyethylene glycerin triisostearate); polyoxyethylene fatty acid esters (eg, polyoxyethylene distearate, polyoxyethylene monodioleate, ethylene glycol distearate etc); Polyoxyethylene alkyl ethers (for example, polyoxyethylene lauryl ether, polyoxyethylene oleyl ether, polyoxyethylene stearyl ether, polyoxyethylene behenyl ether, polyoxyethylene 2-octyldodecyl ether, polyoxyethylene cholestanol ether, etc.) Pluronic types (eg, pluronic etc.); polyoxyethylene / polyoxypropylene alkyl ethers (eg, polyoxyethylene / polyoxy) Cipropylene cetyl ether, polyoxyethylene / polyoxypropylene 2-decyl tetradecyl ether, polyoxyethylene / polyoxypropylene monobutyl ether, polyoxyethylene / polyoxypropylene hydrogenated lanolin, polyoxyethylene / polyoxypropylene glycerin ether, etc. Tetraoxyethylene · tetrapolyoxypropylene ethylenediamine condensates (for example, Tetronic etc.); polyoxyethylene castor oil hydrogenated castor oil derivative (for example, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxy acid) Ethylene-cured castor oil monoisostearate, polyoxyethylene hydrogenated castor oil triisostearate, polyoxyethylene hydrogenated castor oil monopyroglutamic acid monoisostearate Diester, polyoxyethylene hydrogenated castor oil, maleic acid etc.); polyoxyethylene beeswax lanolin derivatives (eg, polyoxyethylene sorbite beeswax etc.); alkanolamides (eg, coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanol Polyamides, ethylene glycol glycol fatty acid esters, polyoxyethylene alkylamines, polyoxyethylene fatty acid amides, sucrose fatty acid esters, alkylethoxydimethylamine oxide, trioleyl phosphate and the like.
天然の水溶性高分子としては、例えば、植物系高分子(例えば、アラビアガム、トラガカントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、ローカストビーンガム、タマリンドガム、カラギーナン、ペクチン、カンテン、クインスシード(マルメロ)、アルゲコロイド(カッソウエキス)、デンプン(コメ、トウモロコシ、バレイショ、コムギ)、グリチルリチン酸);微生物系高分子(例えば、キサンタンガム、デキストラン、サクシノグルカン、ブルラン等);動物系高分子(例えば、コラーゲン、カゼイン、アルブミン、ゼラチン等)等が挙げられる。 Examples of natural water-soluble polymers include plant-based polymers (eg, gum arabic, tragacanth gum, galactan, guar gum, carob gum, karaya gum, locust bean gum, tamarind gum, carrageenan, pectin, agarten, quince seed (maleo), Alge colloid (caustic extract), starch (rice, corn, potato, wheat), glycyrrhizinic acid; microbial macromolecule (for example, xanthan gum, dextran, succinoglucan, bululin etc.); animal macromolecule (for example, collagen, casein , Albumin, gelatin etc.).
半合成の水溶性高分子としては、例えば、デンプン系高分子(例えば、カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等);セルロース系高分子(メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ジアルキルジメチルアンモニウム硫酸セルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロース、カルボキシメチルセルロースナトリウム、結晶セルロース、セルロース末及びこれら高分子の疎水変性化合物<例:一部をステアロキシ変性>及びこれら高分子のカチオン変性化合物等);アルギン酸系高分子(例えば、アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等);ペクチン酸ナトリウム等が挙げられる。 Examples of semi-synthetic water-soluble polymers include starch-based polymers (for example, carboxymethyl starch, methyl hydroxypropyl starch and the like); cellulose-based polymers (methyl cellulose, ethyl cellulose, methyl hydroxypropyl cellulose, hydroxyethyl cellulose, cellulose sodium sulfate) , Dialkyldimethyl ammonium sulfate cellulose, hydroxypropyl cellulose, carboxymethyl cellulose, carboxymethyl cellulose sodium, crystalline cellulose, cellulose powder and hydrophobic modified compounds of these polymers <Example: partially modified with stearoxy> cationic modified compounds of these polymers, etc.) Alginic acid based polymers (eg, sodium alginate, alginic acid propylene glycol ester, etc.); sodium pectate etc. It is below.
合成の水溶性高分子としては、例えば、ビニル系高分子(例えば、ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニルピロリドン、カルボキシビニルポリマー等);ポリオキシエチレン系高分子(例えば、ポリエチレングリコール20,000、40,000、60,000のポリオキシエチレンポリオキシプロピレン共重合体等);ポリ(ジメチルジアリルアンモニウムハライド)型カチオン性高分子(例えば、マーコート100 (Merquat100)米国メルク社製);ジメチルジアリルアンモニウムハライドとアクリルアミドの共重合体型カチオン性ポリマー(例えば、マーコート550(Merquat 550)米国メルク社製);アクリル系高分子(例えば、ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリルアミド等);ポリエチレンイミン;カチオンポリマー;ケイ酸AlMg(ビーガム)、等が挙げられる。 Examples of synthetic water-soluble polymers include vinyl polymers (eg, polyvinyl alcohol, polyvinyl methyl ether, polyvinyl pyrrolidone, carboxyvinyl polymer, etc.); polyoxyethylene polymers (eg, polyethylene glycol 20,000, 40,000, 60,000) (Polyoxyethylene-polyoxypropylene copolymer etc.); poly (dimethyldiallyl ammonium halide) type cationic polymer (for example, Mercot 100 (Merquat 100) manufactured by US Merck & Co., Inc.); copolymer type cation of dimethyldiallyl ammonium halide and acrylamide Polymers (for example, Mercot 550 (Merquat 550) manufactured by Merck, USA); acrylic polymers (for example, sodium polyacrylate, polyethyl acrylate, polyacrylamide etc.); polyethyleneimine; cationic poly Mer; AlMg silicate (bee gum), etc. may be mentioned.
紫外線吸収剤としては、例えば、安息香酸系紫外線吸収剤(例えば、パラアミノ安息香酸(以下、PABAと略す)、PABAモノグリセリンエステル、N,N-ジプロポキシPABAエチルエステル、N,N-ジエトキシPABAエチルエステル、N,N-ジメチルPABAエチルエステル、N,N-ジメチルPABAブチルエステル、N,N-ジメチルPABAエチルエステル等);アントラニル酸系紫外線吸収剤(例えば、ホモメンチル-N- アセチルアントラニレート等);サリチル酸系紫外線吸収剤(例えば、アミルサリシレート、メンチルサリシレート、ホモメンチルサリシレート、オクチルサリシレート、フェニルサリシレート、ベンジルサリシレート、p-イソプロパノールフェニルサリシレート等);桂皮酸系紫外線吸収剤(例えば、オクチルシンナメート、エチル-4-イソプロピルシンナメート、メチル-2,5-ジイソプロピルシンナメート、エチル-2,4-ジイソプロピルシンナメート、メチル-2,4-ジイソプロピルシンナメート、プロピル-p-メトキシシンナメート、イソプロピル-p-メトキシシンナメート、イソアミル-p-メトキシシンナメート、オクチル-p-メトキシシンナメート(2-エチルヘキシル-p-メトキシシンナメート) 、2-エトキシエチル-p-メトキシシンナメート、シクロヘキシル-p-メトキシシンナメート、エチル-α-シアノ-β-フェニルシンナメート、2-エチルヘキシル-α-シアノ-β-フェニルシンナメート、グリセリルモノ-2-エチルヘキサノイル-ジパラメトキシシンナメート等);ベンゾフェノン系紫外線吸収剤(例えば、2,4-ジヒドロキシベンゾフェノン、2,2'- ジヒドロキシ-4- メトキシベンゾフェノン、2,2'-ジヒドロキシ-4,4'-ジメトキシベンゾフェノン、2,2',4,4'-テトラヒドロキシベンゾフェノン、2-ヒドロキシ-4- メトキシベンゾフェノン、2-ヒドロキシ-4- メトキシ-4'-メチルベンゾフェノン、2-ヒドロキシ-4- メトキシベンゾフェノン-5-スルホン酸塩、4-フェニルベンゾフェノン、2-エチルヘキシル-4'-フェニル-ベンゾフェノン-2-カルボキシレート、2-ヒドロキシ-4-n-オクトキシベンゾフェノン、4-ヒドロキシ-3-カルボキシベンゾフェノン等);3-(4'-メチルベンジリデン)-d,l-カンファー、3-ベンジリデン-d,l-カンファー;2-フェニル-5-メチルベンゾキサゾール;2,2'-ヒドロキシ-5-メチルフェニルベンゾトリアゾール;2-(2'-ヒドロキシ-5'-t-オクチルフェニル) ベンゾトリアゾール;2-(2'-ヒドロキシ-5'-メチルフェニルベンゾトリアゾール;ジアニソイルメタン;4-メトキシ-4'-t-ブチルジベンゾイルメタン;5-(3,3-ジメチル-2-ノルボルニリデン)-3-ペンタン-2-オン等);トリアジン系紫外線吸収剤(例えば、2-4[(2-ヒドロキシ-3-ドデシルオキシプロピル)オキシ]-2-ヒドロキシフェニル)-4,6-ビス(2,4-ジメチルフェニル)-1,3,5-トリアジン、2-4[(2-ヒドロキシ-3-トリデシルオキシプロピル)オキシ]-2-ヒドロキシフェニル)-4,6-ビス(2,4-ジメチルフェニル)-1,3,5-トリアジン等)が挙げられる。 Examples of UV absorbers include benzoic acid UV absorbers (for example, paraaminobenzoic acid (hereinafter referred to as PABA), PABA monoglycerin ester, N, N-dipropoxy PABA ethyl ester, N, N-diethoxy PABA ethyl ester N, N-dimethyl PABA ethyl ester, N, N-dimethyl PABA butyl ester, N, N-dimethyl PABA ethyl ester, etc.); anthranilic acid-based UV absorbers (eg, homomentyl-N-acetyl anthranilate etc.); Salicylic acid based UV absorbers (eg, amyl salicylate, menthyl salicylate, homomentyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate, etc.); cinnamic acid based UV absorbers (eg, octyl cinnamate, ethyl- 4-isopropyl cinnamate, methi -2,5-diisopropylcinnamate, ethyl-2,4-diisopropylcinnamate, methyl-2,4-diisopropylcinnamate, propyl-p-methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxy Cinnamate, octyl-p-methoxycinnamate (2-ethylhexyl-p-methoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate, cyclohexyl-p-methoxycinnamate, ethyl-α-cyano-β-phenyl Cinnamate, 2-ethylhexyl-α-cyano-β-phenylcinnamate, glyceryl mono-2-ethylhexanoyl-diparamethoxycinnamate, etc .; benzophenone type UV absorbers (eg, 2,4-dihydroxybenzophenone, 2 , 2'-Dihydroxy-4-methoxybenzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone , 2,2 ', 4,4'-tetrahydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2-hydroxy-4-methoxybenzophenone-5-sulfone Acid salts, 4-phenylbenzophenone, 2-ethylhexyl-4'-phenyl-benzophenone-2-carboxylate, 2-hydroxy-4-n-octoxybenzophenone, 4-hydroxy-3-carboxybenzophenone etc .; 3- ( 4'-methylbenzylidene) -d, l-camphor, 3-benzylidene-d, l-camphor; 2-phenyl-5-methylbenzoxazole; 2,2'-hydroxy-5-methylphenylbenzotriazole; 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole; 2- (2′-hydroxy-5′-methylphenylbenzotriazole; dianisoylmethane; 4-methoxy-4′-t-butyldibenzoylmethane 5- (3) 3, 3-Dimethyl-2-norbornylidene) -3-pentan-2-one, etc.); triazine UV absorbers (eg, 2-4 [(2-hydroxy-3-dodecyloxypropyl) oxy] -2-hydroxyphenyl) ) -4,6-Bis (2,4-dimethylphenyl) -1,3,5-triazine, 2-4 [(2-hydroxy-3-tridecyloxypropyl) oxy] -2-hydroxyphenyl) -4 , 6-bis (2,4-dimethylphenyl) -1,3,5-triazine etc.).
金属イオン封鎖剤としては、例えば、1-ヒドロキシエタン-1,1-ジフォスホン酸、1-ヒドロキシエタン-1,1- ジフォスホン酸四ナトリウム塩、エデト酸二ナトリウム、エデト酸三ナトリウム、エデト酸四ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸、リン酸、クエン酸、アスコルビン酸、コハク酸、エデト酸、エチレンジアミンヒドロキシエチル三酢酸3ナトリウム等が挙げられる。 As a sequestering agent, for example, 1-hydroxyethane-1,1-diphosphonic acid, 1-hydroxyethane-1,1-diphosphonic acid tetrasodium salt, edetate disodium, edetate trisodium, edetate tetrasodium Sodium citrate, sodium polyphosphate, sodium metaphosphate, gluconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid, trisodium ethylenediaminehydroxyethyl triacetate and the like.
pH調整剤としては、例えば、乳酸−乳酸ナトリウム、クエン酸−クエン酸ナトリウム、コハク酸−コハク酸ナトリウム等の緩衝剤等が挙げられる。
ビタミン類としては、例えば、ビタミンA、B1、B2、B6、C、E及びその誘導体、パントテン酸及びその誘導体、ビオチン等が挙げられる。
酸化防止剤としては、例えば、トコフェロール類、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、没食子酸エステル類等が挙げられる。
Examples of pH adjusters include buffers such as lactic acid-sodium lactate, citric acid-sodium citrate, and succinic acid-sodium succinate.
Examples of vitamins include vitamin A, B1, B2, B6, C, E and derivatives thereof, pantothenic acid and derivatives thereof, biotin and the like.
Examples of the antioxidant include tocopherols, dibutylhydroxytoluene, butylhydroxyanisole, gallic acid esters and the like.
酸化防止助剤としては、例えば、リン酸、クエン酸、アスコルビン酸、マレイン酸、マロン酸、コハク酸、フマル酸、ケファリン、ヘキサメタフォスフェイト、フィチン酸、エチレンジアミン四酢酸等が挙げられる。 Examples of the antioxidant aid include phosphoric acid, citric acid, ascorbic acid, maleic acid, malonic acid, succinic acid, fumaric acid, kephalin, hexametaphosphate, phytic acid, ethylenediaminetetraacetic acid and the like.
その他の配合可能成分としては、例えば、防腐剤(エチルパラベン、ブチルパラベン、1,2−アルカンジオール、フェノキシエタノール、メチルクロロイソチオゾリンオン等);消炎剤(例えば、グリチルリチン酸誘導体、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキチオール、酸化亜鉛、アラントイン等);美白剤(例えば、ユキノシタ抽出物、アルブチン等);各種抽出物(例えば、オウバク、オウレン、シコン、シャクヤク、センブリ、バーチ、セージ、ビワ、ニンジン、アロエ、ゼニアオイ、アイリス、ブドウ、ヨクイニン、ヘチマ、ユリ、サフラン、センキュウ、ショウキュウ、オトギリソウ、オノニス、ニンニク、トウガラシ、チンピ、トウキ、海藻等)、賦活剤(例えば、ローヤルゼリー、感光素、コレステロール誘導体等);血行促進剤(例えば、ノニル酸ワレニルアミド、ニコチン酸ベンジルエステル、ニコチン酸β−ブトキシエチルエステル、カプサイシン、ジンゲロン、カンタリスチンキ、イクタモール、タンニン酸、α−ボルネオール、ニコチン酸トコフェロール、イノシトールヘキサニコチネート、シクランデレート、シンナリジン、トラゾリン、アセチルコリン、ベラパミル、セファランチン、γ−オリザノール等);抗脂漏剤(例えば、硫黄、チアントール等);抗炎症剤(例えば、トラネキサム酸、チオタウリン、ヒポタウリン等);芳香族アルコール(ベンジルアルコール、ベンジルオキシエタノール等)等が挙げられる。 Other components which can be incorporated include, for example, preservatives (ethylparaben, butylparaben, 1,2-alkanediol, phenoxyethanol, methylchloroisothiozoline etc.); anti-inflammatory agents (eg, glycyrrhizin acid derivative, glycyrrhetinic acid derivative, Salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, etc .; Whitening agents (eg, Yukinoshita extract, arbutin etc.); Various extracts (eg, Oupaku, ouren, shikon, peony, cerebrum, birch, sage, loquat, carrot, aloe , Zebra oasis, iris, grape, yokinin, oats, lily, saffron, sage, sage, oonilis, ononis, garlic, pepper, chinpi, seaweed etc., activator (eg royal jelly, photosensitizer, cholesterol) Conductors and the like); blood circulation promoting agents (eg, nonyl acid warenylamide, nicotinic acid benzyl ester, nicotinic acid β-butoxyethyl ester, capsaicin, zingerone, cantaristine key, ictamol, tannic acid, α-borneol, tocopherol nicotinate, inositol hexahydrate Nicotinate, cichrandelate, cinnarizine, trazoline, acetylcholine, verapamil, cephalantin, γ-oryzanol etc .; antiseborrhoeic agent (eg sulfur, thianthol etc.); anti-inflammatory agent (eg tranexamic acid, thiotaurine, hypotaurine etc) And aromatic alcohols (benzyl alcohol, benzyloxyethanol etc.) and the like.
また、その他、香料、スクラブ剤なども、安定性を損なわない範囲で適宜配合することができる In addition, other ingredients such as perfumes and scrub agents can be appropriately blended within the range that does not impair the stability.
以下、本発明を実施例により更に詳細に説明するが、本発明はこれらにより限定されるものではない。なお、特に記載のない限り、配合量については全て質量%で示す。
Hereinafter, the present invention will be described in more detail by way of examples, but the present invention is not limited thereto. In addition, about a compounding quantity, it shows by the mass% unless there is particular mention.
[αゲルのオクルージョン効果の比較]
以下の実施例、比較例にかかる組成物をを70℃、超音波ホモゲナイザーで調製し、冷却後、紙にそれぞれ5mg/cm2の割合で均一塗布して1日放置した。恒温恒湿室(23℃ 、相対湿度= 45%)中において、25mL容バイアル瓶に5mLの水を入れた後、直ちにバイアルの蓋部に該ろ紙を挟んで固定し、継時で水分蒸発量を測定した。時間当たりの水分蒸発量(減衰質量%)を水分蒸発速度定数(%/時間)と定義した。従って、水分蒸発速度定数(%/時間)が小さいほど、水分を保持する能力が高いことになる。
実施例1
配合量
(1)ステアリルアルコール 12.5%
(2)ポリオキシエチレン(10モル)フィトステロール 30.0%
(3)ポリオキシエチレン(6モル)ジステアリン酸 7.5%
(4)イオン交換水 50.0%
実施例2
配合量
(1)ステアリン酸 12.5%
(2)ポリオキシエチレン(10モル)フィトステロール 30.0%
(3)ポリオキシエチレン(6モル)ジステアリン酸 7.5%
(4)イオン交換水 50.0%
実施例3
配合量
(1)ベヘニルアルコール 15.0%
(2)ポリオキシエチレン(20モル)フィトステロール 30.0%
(3)ポリオキシエチレン(4モル)ジステアリン酸 5.0%
(4)イオン交換水 50.0%
比較例1
配合量
(1)ベヘニルアルコール 34.1%
(2)N-ステアロイルメチルタウリンナトリウム 15.9%
(3)イオン交換水 50.0%
比較例2
配合量
(1)ベヘニルアルコール 30.0%
(2)ポリオキシエチレン(20モル)ベヘニルエーテル 20.0%
(3)イオン交換水 50.0%
比較例3
配合量
(1)ステアリルアルコール 12.5%
(2)ポリオキシエチレン(10モル)フィトステロール 30.0%
(3)大豆水素添加レシノール 7.5%
(4)イオン交換水 50.0%
[Comparison of alpha gel occlusion effect]
The compositions according to the following examples and comparative examples were prepared with an ultrasonic homogenizer at 70 ° C., cooled, uniformly coated on paper at a rate of 5 mg / cm 2 each, and allowed to stand for 1 day. After putting 5 mL of water in a 25 mL vial in a constant temperature and humidity chamber (23 ° C., relative humidity = 45%), immediately fix the filter paper on the lid of the vial and fix the amount of water evaporation at the passage Was measured. The water evaporation rate (decay mass%) per hour was defined as the water evaporation rate constant (% / hour). Therefore, the smaller the moisture evaporation rate constant (% / hour), the higher the ability to retain water.
Example 1
Blending amount (1) Stearyl alcohol 12.5%
(2) Polyoxyethylene (10 moles) phytosterol 30.0%
(3) Polyoxyethylene (6 moles) distearic acid 7.5%
(4) Ion-exchanged water 50.0%
Example 2
Compounding amount (1) Stearic acid 12.5%
(2) Polyoxyethylene (10 moles) phytosterol 30.0%
(3) Polyoxyethylene (6 moles) distearic acid 7.5%
(4) Ion-exchanged water 50.0%
Example 3
Compounding amount (1) Behenyl alcohol 15.0%
(2) Polyoxyethylene (20 moles) phytosterol 30.0%
(3) Polyoxyethylene (4 moles) distearic acid 5.0%
(4) Ion-exchanged water 50.0%
Comparative Example 1
Compounding amount (1) Behenyl alcohol 34.1%
(2) N-stearoyl methyl taurine sodium 15.9%
(3) Ion-exchanged water 50.0%
Comparative example 2
Compounding amount (1) Behenyl alcohol 30.0%
(2) Polyoxyethylene (20 moles) behenyl ether 20.0%
(3) Ion-exchanged water 50.0%
Comparative example 3
Blending amount (1) Stearyl alcohol 12.5%
(2) Polyoxyethylene (10 moles) phytosterol 30.0%
(3) Soy Hydrogenated Resin Resinol 7.5%
(4) Ion-exchanged water 50.0%
結果
結果を表1に示した。表1から明らかなように、本発明のαゲル(実施例1〜3)はベヘニルアルコールとN-ステアロイルメチルタウリンナトリウム、ベヘニルアルコールとポリオキシエチレン(20モル)ベヘニルエーテル、ステアリルアルコールとポリオキシエチレン(10モル)フィトステロールと大豆水素添加レシノールを用いた比較例1〜3のαゲル基剤に比べて、オクル―ジョン効果が高いことがわかった。
Results The results are shown in Table 1. As is clear from Table 1, the alpha gels (Examples 1 to 3) of the present invention are behenyl alcohol and N-stearoylmethyltaurine sodium, behenyl alcohol and polyoxyethylene (20 moles) behenyl ether, stearyl alcohol and polyoxyethylene (10 The occluding effect was found to be higher than that of Comparative Examples 1 to 3 of Comparative Examples 1 to 3 in which the molar sterol and soybean hydrogenated resin were used.
[粘度安定性試験]
更に、実施例1〜3、比較例1〜3の基剤をそれぞれ75℃にてイオン交換水で10倍に希釈し、0〜50℃の各温度に保存し、経時での粘度を30℃で30分以上保持した後、B型粘度計で粘度(mPa・s)を測定した。
結果
結果を表2に示した。表から明らかなように、実施例1〜3及び比較例3では粘度は安定していたが、比較例1、2では経時での増粘が認められた。なお、粘度が安定していた比較例3は変臭が認められた。
[Viscosity stability test]
Furthermore, the base of each of Examples 1 to 3 and Comparative Examples 1 to 3 is diluted 10 times with ion exchange water at 75 ° C., stored at each temperature of 0 to 50 ° C., and the viscosity over time is 30 ° C. After holding for 30 minutes or longer, the viscosity (mPa · s) was measured with a B-type viscometer.
Results The results are shown in Table 2. As apparent from the table, in Examples 1 to 3 and Comparative Example 3, the viscosity was stable, but in Comparative Examples 1 and 2, thickening over time was observed. In addition, the strange smell was recognized by the comparative example 3 whose viscosity was stable.
[臭い安定性]
実施例4〜6、比較例4〜6の基剤をそれぞれ75℃にてイオン交換水で10倍に希釈し、50℃の各温度に保存し、1か月後の臭いを専門パネルによって、以下の判定基準で判定した。
判定基準
○:問題なし、△:やや変臭、×:変臭
実施例4
配合量
(1)ステアリルアルコール 12.5%
(2)ポリオキシエチレン(10モル)フィトステロール 30.0%
(3)ポリオキシエチレン(6モル)ジステアリン酸 6.0%
(4)大豆水素添加レシノール 1.5%
(5)イオン交換水 50.0%
実施例5
配合量
(1)ステアリン酸 12.5%
(2)ポリオキシエチレン(10モル)フィトステロール 30.0%
(3)ポリオキシエチレン(6モル)ジステアリン酸 7.0%
(4)セラミドIII 0.5%
(5)イオン交換水 50.0%
実施例6
配合量
(1)ベヘニルアルコール 15.0%
(2)ポリオキシエチレン(20モル)フィトステロール 30.0%
(3)ポリオキシエチレン(4モル)ジステアリン酸 4.8%
(4)ジステアリル4級アンモニウムクロライド 0.2%
(5)イオン交換水 50.0%
比較例4
配合量
(1)ベヘニルアルコール 34.1%
(2)N-ステアロイルメチルタウリンナトリウム 14.4%
(3)大豆水素添加レシノール 1.5%
(4)イオン交換水 50.0%
比較例5
配合量
(1)ベヘニルアルコール 30.0%
(2)ポリオキシエチレン(20モル)ベヘニルエーテル 19.5%
(3)セラミドIII 0.5%
(4)イオン交換水 50.0%
比較例6
配合量
(1)ステアリルアルコール 12.5%
(2)ポリオキシエチレン(10モル)フィトステロール 30.0%
(3)ジステアリル4級アンモニウムクロライド 7.5%
(4)イオン交換水 50.0%
[Odor stability]
The bases of Examples 4 to 6 and Comparative Examples 4 to 6 are each diluted 10-fold with ion-exchanged water at 75 ° C., stored at each temperature of 50 ° C., and the odor after one month is obtained by a specialized panel. It judged by the following judgment criteria.
Judgment criteria :: no problem :: somewhat strange odor, x: strange odor
Example 4
Blending amount (1) Stearyl alcohol 12.5%
(2) Polyoxyethylene (10 moles) phytosterol 30.0%
(3) Polyoxyethylene (6 moles) distearic acid 6.0%
(4) Soy hydrogenation hydrogenated resinol 1.5%
(5) Ion-exchanged water 50.0%
Example 5
Compounding amount (1) Stearic acid 12.5%
(2) Polyoxyethylene (10 moles) phytosterol 30.0%
(3) Polyoxyethylene (6 moles) distearic acid 7.0%
(4) Ceramide III 0.5%
(5) Ion-exchanged water 50.0%
Example 6
Compounding amount (1) Behenyl alcohol 15.0%
(2) Polyoxyethylene (20 moles) phytosterol 30.0%
(3) Polyoxyethylene (4 moles) distearic acid 4.8%
(4) Distearyl quaternary ammonium chloride 0.2%
(5) Ion-exchanged water 50.0%
Comparative example 4
Compounding amount (1) Behenyl alcohol 34.1%
(2) N-stearoylmethyltaurine sodium 14.4%
(3) Soy hydrogenation hydrogenated resinol 1.5%
(4) Ion-exchanged water 50.0%
Comparative example 5
Compounding amount (1) Behenyl alcohol 30.0%
(2) Polyoxyethylene (20 moles) behenyl ether 19.5%
(3) Ceramide III 0.5%
(4) Ion-exchanged water 50.0%
Comparative example 6
Blending amount (1) Stearyl alcohol 12.5%
(2) Polyoxyethylene (10 moles) phytosterol 30.0%
(3) Distearyl quaternary ammonium chloride 7.5%
(4) Ion-exchanged water 50.0%
結果
結果を表3に示した。表3から明らかなように、本発明のαゲル組成物を用いることによって、リン脂質、レシチン、リゾレシチン、セラミド、ジアルキル4級アンモニウム塩などの窒素原子を有する2鎖型両親媒性物質の変臭がなくなることがわかった。
Results The results are shown in Table 3. As apparent from Table 3, by using the α-gel composition of the present invention, it is possible to change the odor of a two-chain amphiphilic substance having a nitrogen atom such as phospholipid, lecithin, lysolecithin, ceramide, dialkyl quaternary ammonium salt, etc. It turned out that
以下、より具体的な実施例を挙げて本発明について更に説明を行うが、本発明はこれに限定されるものではない。
実施例7
乳液 配合量(質量%)
(1)ステアリルアルコール 1.3
(2)ポリオキシエチレン(10モル)フィトステロール 3.0
(3)ポリオキシエチレン(6モル)ジステアリン酸 0.6
(4)ジプロピレングリコール 5.0
(5)香料 0.1
(6)テトラ2−エチルヘキサン酸ペンタエリトリット 2.0
(7)αオレフィンオリゴマー 3.0
(8)ジメチルポリシロキサン 2.0
(信越化学株式会社製、シリコーンKF96−A6T)
(9)精製ワセリン 1.0
(10)1,3−ブチレングリコール 2.0
(11)フェノキシエタノール 0.5
(12)グリセリン 4.0
(13)カルボキシビニルポリマー 0.03
(14)水酸化カリウム 0.01
(15)トラネキサム酸 0.1
(16)クエン酸 0.02
(17)クエン酸ナトリウム 0.08
(18)イオン交換水 残余
(製法)
常法により乳化して、上記乳液を得た。得られた乳液は、オクル―ジョン効果が高く、さっぱりしており、粘度安定性及び臭い安定性が良好であった。
Hereinafter, the present invention will be further described with reference to more specific examples, but the present invention is not limited thereto.
Example 7
Emulsion content (mass%)
(1) Stearyl alcohol 1.3
(2) Polyoxyethylene (10 moles) phytosterol 3.0
(3) Polyoxyethylene (6 moles) distearic acid 0.6
(4) Dipropylene glycol 5.0
(5) Flavoring agent 0.1
(6) Tetraerythritol 2-ethylhexanoic acid pentaerythritol 2.0
(7) α-olefin oligomer 3.0
(8) Dimethylpolysiloxane 2.0
(Shin-Etsu Chemical Co., Ltd., silicone KF96-A6T)
(9) Purified Vaseline 1.0
(10) 1,3-butylene glycol 2.0
(11) Phenoxyethanol 0.5
(12) Glycerin 4.0
(13) Carboxyvinyl polymer 0.03
(14) Potassium hydroxide 0.01
(15) tranexamic acid 0.1
(16) citric acid 0.02
(17) Sodium citrate 0.08
(18) Ion-exchanged water residue (process)
The emulsion was obtained by emulsification according to a conventional method. The obtained emulsion had a high occluding effect, was refreshing, and had good viscosity stability and odor stability.
実施例8
美容液 配合量(質量%)
(1)N−ステアロイルメチルタウリンナトリウム 0.01
(2)ステアリルアルコール 0.13
(3)ポリオキシエチレン(10モル)フィトステロール 0.3
(4)ポリオキシエチレン(6モル)ジステアリン酸 0.06
(5)流動パラフィン 0.78
(6)メチルフェニルポリシロキサン 0.2
(信越化学株式会社製、シリコーンKF56)
(7)香料 0.02
(8)ポリオキシエチレン(14モル)ホ゜リオキシフ゜ロヒ゜レン(7モル)シ゛メチルエーテル 0.5
(9)グリセリン 3.0
(10)ジプロピレングリコール 5.0
(11)1,3−ブチレングリコール 3.0
(12)クエン酸 0.02
(13)クエン酸ナトリウム 0.08
(14) EDTA2Na・2H2O 0.01
(15)一般アルコール95% 5.0
(16)フェノキシエタノール 0.5
(17)イオン交換水 残余
(製法)
常法により乳化して、上記美容液を得た。得られた美容液は、オクル―ジョン効果が高く、さっぱりしており、粘度安定性及び臭い安定性が良好であった。
Example 8
Amount of cosmetic solution (mass%)
(1) N-stearoyl methyl taurine sodium 0.01
(2) Stearyl alcohol 0.13
(3) Polyoxyethylene (10 moles) phytosterol 0.3
(4) Polyoxyethylene (6 moles) distearic acid 0.06
(5) Liquid paraffin 0.78
(6) Methylphenylpolysiloxane 0.2
(Shin-Etsu Chemical Co., Ltd., silicone KF56)
(7) Perfume 0.02
(8) Polyoxyethylene (14 moles) propylene (7 moles) dimethyl ether 0.5
(9) Glycerin 3.0
(10) Dipropylene glycol 5.0
(11) 1,3-butylene glycol 3.0
(12) Citric acid 0.02
(13) Sodium citrate 0.08
(14) EDTA2Na · 2H2O 0.01
(15) General alcohol 95% 5.0
(16) Phenoxyethanol 0.5
(17) Ion-exchanged water residue (process)
The above cosmetic liquid was obtained by emulsifying according to a conventional method. The cosmetic solution obtained had a high occluding effect, was refreshing, and had good viscosity stability and odor stability.
実施例9
乳液 配合量(質量%)
(1)ステアリルアルコール 1.3
(2)ポリオキシエチレン(10モル)フィトステロール 3.0
(3)ポリオキシエチレン(6モル)ジステアリン酸 0.6
(4)大豆水素添加レシノール 0.2
(5)イソプレングリコール 4.5
(6)1,4−ブタンジオール 1.5
(7)香料 0.09
(8)トリステアリン酸グリセリル 2.5
(9)スクワラン 4.5
(10)ジメチルポリシロキサン 1.0
(信越化学株式会社製、シリコーンKF96−A6T)
(11)プロピレングリコール 7.0
(12)エリスリトール 1.3
(13)ダイナマイトグリセリン 6.0
(14)フェノキシエタノール 0.3
(15)キサンタンガム 0.5
(16)ヘキサメタリン酸ソーダ 0.03
(17)イオン交換水 残余
(製法)
常法により乳化して、上記乳液を得た。得られた乳液は、オクル―ジョン効果が高く、さっぱりしており、粘度安定性及び臭い安定性が良好であった。
Example 9
Emulsion content (mass%)
(1) Stearyl alcohol 1.3
(2) Polyoxyethylene (10 moles) phytosterol 3.0
(3) Polyoxyethylene (6 moles) distearic acid 0.6
(4) Soy hydrogenated hydrogenated resinol 0.2
(5) isoprene glycol 4.5
(6) 1,4-butanediol 1.5
(7) Perfume 0.09
(8) Glyceryl tristearate 2.5
(9) Squaran 4.5
(10) Dimethylpolysiloxane 1.0
(Shin-Etsu Chemical Co., Ltd., silicone KF96-A6T)
(11) Propylene glycol 7.0
(12) erythritol 1.3
(13) Dynamite Glycerin 6.0
(14) Phenoxyethanol 0.3
(15) Xanthan gum 0.5
(16) Sodium hexametaphosphate 0.03
(17) Ion-exchanged water residue (process)
The emulsion was obtained by emulsification according to a conventional method. The obtained emulsion had a high occluding effect, was refreshing, and had good viscosity stability and odor stability.
実施例10
日焼け止めクリーム 配合量(質量%)
(1)ベヘニルアルコール 1.5
(2)ポリオキシエチレン(20モル)フィトステロール 3.0
(3)ポリオキシエチレン(4モル)ジステアリン酸 0.5
(4)セラミドII 0.2
(5)ジプロピレングリコール 6.0
(6)香料 0.08
(7)トリ2−エチルヘキサン酸グリセリル 2.0
(8)コハク酸ジ2−エチルヘキシル 3.0
(9)p−メトキシケイヒ酸2−エチルヘキシル 5.0
(10)アボベンゾン 3.0
(11)ビスエチルヘキシルオキシフェノールメトキシフェニル 1.0
トリアジン
(12)1,3−ブチレングリコール 5.0
(13)フェノキシエタノール 0.5
(14)グリセリン 9.0
(15)EDTA−3ナトリウム塩 0.1
(16)エリスリトール 0.1
(17)クエン酸 0.02
(18)クエン酸ナトリウム 0.08
(19)イオン交換水 残余
(製法)
常法により乳化して、上記日焼け止めクリームを得た。得られた日焼け止めクリームは、オクル―ジョン効果が高く、さっぱりしており、粘度安定性及び臭い安定性が良好であった。
Example 10
Amount of sunscreen cream (mass%)
(1) Behenyl alcohol 1.5
(2) Polyoxyethylene (20 moles) phytosterol 3.0
(3) Polyoxyethylene (4 moles) distearic acid 0.5
(4) Ceramide II 0.2
(5) Dipropylene glycol 6.0
(6) Perfume 0.08
(7) Glyceryl tri 2-ethylhexanoate 2.0
(8) Di 2-ethylhexyl succinate 3.0
(9) p-Methoxycinnamic acid 2-ethylhexyl 5.0
(10) Avobenzone 3.0
(11) Bisethylhexyl oxyphenol methoxyphenyl 1.0
Triazine
(12) 1,3-butylene glycol 5.0
(13) Phenoxyethanol 0.5
(14) Glycerin 9.0
(15) EDTA-3 sodium salt 0.1
(16) erythritol 0.1
(17) citric acid 0.02
(18) Sodium citrate 0.08
(19) Ion exchange water residual
(Manufacturing method)
The emulsion was emulsified according to a conventional method to obtain the above-mentioned sunscreen cream. The resulting sunscreen cream had a high occluding effect, was refreshing, and had good viscosity stability and odor stability.
実施例11
クリーム 配合量(質量%)
(1)ステアリルアルコール 2.5
(2)ポリオキシエチレン(10モル)フィトステロール 6.0
(3)ポリオキシエチレン(6モル)ジステアリン酸 1.2
(4)1,3−ブチレングリコール 6.5
(5)香料 0.05
(6)ジメチルポリシロキサン 7.4
(信越化学株式会社製、シリコーンKF96−A6T)
(7)スクワラン 4.0
(8)精製ワセリン 1.0
(9)ジプロピレングリコール 5.0
(10)フェノキシエタノール 0.5
(11)グリセリン 7.0
(12)EDTA−3ナトリウム塩 0.1
(13)カミツレエキス 0.1
(14)クエン酸 0.02
(15)クエン酸ナトリウム 0.08
(製法)
常法により乳化して、クリームを得た。得られたクリームは、オクル―ジョン効果が高く、さっぱりしており、粘度安定性及び臭い安定性が良好であった。
Example 11
Amount of cream (mass%)
(1) Stearyl alcohol 2.5
(2) Polyoxyethylene (10 moles) phytosterol 6.0
(3) Polyoxyethylene (6 moles) distearic acid 1.2
(4) 1,3-butylene glycol 6.5
(5) Perfume 0.05
(6) Dimethylpolysiloxane 7.4
(Shin-Etsu Chemical Co., Ltd., silicone KF96-A6T)
(7) Squaran 4.0
(8) Purified Vaseline 1.0
(9) Dipropylene glycol 5.0
(10) Phenoxyethanol 0.5
(11) Glycerin 7.0
(12) EDTA-3 sodium salt 0.1
(13) Chamomile extract 0.1
(14) Citric acid 0.02
(15) Sodium citrate 0.08
(Manufacturing method)
Emulsify by a conventional method to obtain a cream. The obtained cream had a high occluding effect, was refreshing, and had good viscosity stability and odor stability.
Claims (5)
(B)下記一般式(I)で表されるポリオキシエチレンステロールエーテル40〜70質量%
(I)
(ただし、一般式IでRはコレステロール及び/またはフィトステロール残基、nは5〜20の整数を表わす。)
(C)下記一般式(II)で表されるポリオキシエチレンジアルキルエステル及び/またはエーテルを5〜20質量%
(II)
(ただし、一般式IIでR1及びR2は炭素数16〜24の直鎖脂肪族酸残基または直鎖脂肪族アルコール残基、nは4〜15の整数)
を含み、水を加えることによって生成するαゲル形成用組成物。
(A) 25 to 50 mass% of one or more higher aliphatic alcohol having 16 or more carbon atoms and / or higher fatty acid
(B) 40 to 70 mass% of polyoxyethylene sterol ether represented by the following general formula (I)
(I)
(However, in general formula I, R is a cholesterol and / or phytosterol residue, n is an integer of 5 to 20.)
(C) 5 to 20% by mass of polyoxyethylene dialkyl ester and / or ether represented by the following general formula (II)
(II)
(However, in the general formula II, R 1 and R 2 are linear aliphatic acid residues having 16 to 24 carbon atoms or linear aliphatic alcohol residues, and n is an integer of 4 to 15)
And a composition for forming an alpha gel formed by adding water .
The alpha gel composition prepared by mix | blending (A)-(C) of Claim 1 in water.
The alpha gel composition according to claim 2, further comprising 0.1 to 10% by mass of a two-chain amphiphile having a nitrogen atom with respect to the effective component in the alpha gel composition. Composition.
The α-gel composition according to claim 3, wherein the two-chain amphiphilic substance having a nitrogen atom is one or more selected from phospholipids, lecithin, lysolecithin, ceramide and dialkyl quaternary ammonium salts. An alpha gel composition comprising:
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016013181A JP6426635B2 (en) | 2016-01-27 | 2016-01-27 | Composition for alpha gel formation and alpha gel composition |
| PCT/JP2017/000243 WO2017130655A1 (en) | 2016-01-27 | 2017-01-06 | α-GEL FORMATION COMPOSITION AND α-GEL COMPOSITION |
| EP17743889.2A EP3417845B1 (en) | 2016-01-27 | 2017-01-06 | Alpha-gel formation composition and alpha-gel composition |
| US16/073,201 US11033479B2 (en) | 2016-01-27 | 2017-01-06 | Alpha-gel forming composition and alpha-gel composition |
| CN201780008407.0A CN108472224B (en) | 2016-01-27 | 2017-01-06 | Composition for forming alpha gel and alpha gel composition |
| KR1020187024167A KR102757341B1 (en) | 2016-01-27 | 2017-01-06 | Composition for forming α-gel and α-gel composition |
| RU2018128456A RU2732289C2 (en) | 2016-01-27 | 2017-01-06 | Composition for forming alpha-gel and composition of alpha-gel |
| BR112018015257-9A BR112018015257B1 (en) | 2016-01-27 | 2017-01-06 | COMPOSITION FOR ALPHA-GEL FORMATION, ALPHA-GEL COMPOSITION AND EXTERNAL SKIN PREPARATION COMPOSITION |
| AU2017212886A AU2017212886A1 (en) | 2016-01-27 | 2017-01-06 | Alpha-gel formation composition and alpha-gel composition |
| TW106101682A TWI740882B (en) | 2016-01-27 | 2017-01-18 | α-GEL FORMING COMPOSITION AND α-GEL COMPOSITION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016013181A JP6426635B2 (en) | 2016-01-27 | 2016-01-27 | Composition for alpha gel formation and alpha gel composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017132709A JP2017132709A (en) | 2017-08-03 |
| JP6426635B2 true JP6426635B2 (en) | 2018-11-21 |
Family
ID=59398008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016013181A Active JP6426635B2 (en) | 2016-01-27 | 2016-01-27 | Composition for alpha gel formation and alpha gel composition |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11033479B2 (en) |
| EP (1) | EP3417845B1 (en) |
| JP (1) | JP6426635B2 (en) |
| KR (1) | KR102757341B1 (en) |
| CN (1) | CN108472224B (en) |
| AU (1) | AU2017212886A1 (en) |
| BR (1) | BR112018015257B1 (en) |
| RU (1) | RU2732289C2 (en) |
| TW (1) | TWI740882B (en) |
| WO (1) | WO2017130655A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021205902A1 (en) * | 2020-04-06 | 2021-10-14 | 株式会社 資生堂 | Lamellar gel-containing composition, emulsified composition, and composition for agent for external use on skin |
| CN115942929A (en) * | 2020-07-09 | 2023-04-07 | 株式会社资生堂 | Oil-in-water emulsion composition |
| JP7821035B2 (en) * | 2021-05-17 | 2026-02-26 | 株式会社 資生堂 | Oil-in-water emulsion cosmetics |
| CN119947692A (en) * | 2022-10-07 | 2025-05-06 | 株式会社资生堂 | Gel composition and oil-in-water composition |
| WO2025216148A1 (en) * | 2024-04-09 | 2025-10-16 | 株式会社 資生堂 | Gel composition and oil-in-water composition |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5121409A (en) | 1974-08-16 | 1976-02-20 | Takamisawa Electric Co | Kokankitono setsuzokuhoshiki |
| JPS5690074U (en) | 1979-12-14 | 1981-07-18 | ||
| FR2539324B1 (en) * | 1983-01-19 | 1989-11-17 | Oreal | NOVEL EMULSIFYING SYSTEM BASED ON FATTY ACID, POLYOXYETHYLENE STEROL AND PHOSPHATIDE AND ITS USE FOR OBTAINING COSMETIC OR PHARMACEUTICAL COMPOSITIONS |
| WO1998054271A1 (en) * | 1997-05-30 | 1998-12-03 | Shiseido Company, Ltd. | Gelling agent and gel compositions |
| JP2000001423A (en) * | 1998-06-15 | 2000-01-07 | New Japan Chem Co Ltd | Oil solution for cosmetic and cosmetic |
| US6881776B2 (en) * | 1998-10-29 | 2005-04-19 | Penreco | Gel compositions |
| JP4495941B2 (en) | 2003-02-19 | 2010-07-07 | 株式会社コーセー | Oil-in-water emulsified cosmetic |
| DE102004021312A1 (en) | 2004-04-29 | 2005-11-24 | Cognis Ip Management Gmbh | Emulsifier concentrate for cosmetic composition |
| JP5101808B2 (en) * | 2004-09-16 | 2012-12-19 | 株式会社コーセー | Oil-in-water liquid composition |
| CN1944482B (en) * | 2006-09-21 | 2012-05-09 | 北京科技大学 | A kind of gel polymer for gel injection molding and preparation method thereof |
| FR2917614B1 (en) * | 2007-06-21 | 2009-10-02 | Oreal | COSMETIC COMPOSITION COMPRISING A POLYESTER AND A BRANCHED HYDROCARBON COMPOUND. |
| JP5508682B2 (en) * | 2007-07-27 | 2014-06-04 | 株式会社 資生堂 | Oil-in-water emulsion composition and method for producing the same |
| JP2009057515A (en) * | 2007-09-03 | 2009-03-19 | Mitsubishi Chemicals Corp | Gelling agent, gel-like composition and use thereof |
| TWI414317B (en) * | 2008-05-29 | 2013-11-11 | 資生堂股份有限公司 | Skin external preparation |
| JP2010120857A (en) * | 2008-11-17 | 2010-06-03 | Doctor Program Kk | Skin external preparation |
| JP4613258B2 (en) * | 2009-02-03 | 2011-01-12 | 株式会社資生堂 | Hair conditioner composition and low energy production method thereof |
| JP5690516B2 (en) * | 2009-07-06 | 2015-03-25 | 花王株式会社 | Emulsified composition |
| MX343424B (en) * | 2010-11-11 | 2016-11-04 | Unilever Nv | Leave-on nonsolid skin conditioning compositions containing 12-hydroxystearic acid. |
| US11813284B2 (en) * | 2013-08-08 | 2023-11-14 | Novan, Inc. | Topical compositions and methods of using the same |
| WO2015190306A1 (en) * | 2014-06-13 | 2015-12-17 | 株式会社 資生堂 | α-GEL-INTERMEDIATE COMPOSITION, AND PRODUCTION METHOD FOR α-GEL-CONTAINING O/W EMULSION COSMETIC USING SAID COMPOSITION |
| US10898426B2 (en) * | 2016-01-27 | 2021-01-26 | Shiseido Company, Ltd. | Alpha-gel formation composition, external skin care composition using alpha-gel formation composition, and alpha-gel composition using alpha-gel formation composition |
| CN108472230B (en) * | 2016-01-27 | 2021-04-20 | 株式会社资生堂 | Composition for forming alpha gel, and external skin composition and alpha gel composition using the same |
| CN107693844A (en) * | 2016-08-07 | 2018-02-16 | 李媚 | A kind of composition gels and application |
-
2016
- 2016-01-27 JP JP2016013181A patent/JP6426635B2/en active Active
-
2017
- 2017-01-06 EP EP17743889.2A patent/EP3417845B1/en active Active
- 2017-01-06 BR BR112018015257-9A patent/BR112018015257B1/en active IP Right Grant
- 2017-01-06 US US16/073,201 patent/US11033479B2/en active Active
- 2017-01-06 RU RU2018128456A patent/RU2732289C2/en active
- 2017-01-06 KR KR1020187024167A patent/KR102757341B1/en active Active
- 2017-01-06 CN CN201780008407.0A patent/CN108472224B/en active Active
- 2017-01-06 WO PCT/JP2017/000243 patent/WO2017130655A1/en not_active Ceased
- 2017-01-06 AU AU2017212886A patent/AU2017212886A1/en not_active Abandoned
- 2017-01-18 TW TW106101682A patent/TWI740882B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3417845A4 (en) | 2019-07-03 |
| JP2017132709A (en) | 2017-08-03 |
| KR20180104091A (en) | 2018-09-19 |
| RU2018128456A3 (en) | 2020-02-27 |
| WO2017130655A1 (en) | 2017-08-03 |
| BR112018015257A2 (en) | 2018-12-18 |
| EP3417845A1 (en) | 2018-12-26 |
| CN108472224A (en) | 2018-08-31 |
| US20210100732A1 (en) | 2021-04-08 |
| RU2018128456A (en) | 2020-02-27 |
| US11033479B2 (en) | 2021-06-15 |
| EP3417845B1 (en) | 2021-03-31 |
| AU2017212886A1 (en) | 2018-08-16 |
| BR112018015257B1 (en) | 2021-11-16 |
| TW201801710A (en) | 2018-01-16 |
| KR102757341B1 (en) | 2025-01-17 |
| RU2732289C2 (en) | 2020-09-15 |
| CN108472224B (en) | 2021-05-07 |
| TWI740882B (en) | 2021-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6136043B1 (en) | Ripple phase-containing composition, α-gel-forming composition, and external composition for skin and α-gel composition using the same | |
| ES2519468T3 (en) | Composition of oil-in-water emulsion and preparation procedure | |
| ES2710297T3 (en) | Intermediate alpha gel compositions, and production process for O / W emulsion cosmetic containing alpha gel using said composition | |
| ES2724463T3 (en) | Intermediate composition of alpha gel, and production process for cosmetic in O / W emulsion containing alpha gel using said composition | |
| KR19980069385A (en) | UV absorbing composition | |
| JP6426635B2 (en) | Composition for alpha gel formation and alpha gel composition | |
| JPH0640886A (en) | Skin external preparation | |
| JP5134778B2 (en) | Gel composition and pack cosmetic using the gel composition | |
| EP4134067A1 (en) | Lamellar gel-containing composition, emulsified composition, and composition for agent for external use on skin | |
| US10898426B2 (en) | Alpha-gel formation composition, external skin care composition using alpha-gel formation composition, and alpha-gel composition using alpha-gel formation composition | |
| JP5530052B2 (en) | Skin cleanser | |
| JP3520149B2 (en) | External preparation for skin roughening | |
| JPH11106325A (en) | Skin lotion | |
| WO2022009709A1 (en) | Oil-in-water emulsion composition | |
| WO2024135300A1 (en) | Cosmetic composition, cosmetic composition for suppressing discoloration, and discoloration suppressant | |
| JP2005162715A (en) | Skin whitening agent and external preparation for skin whitening containing the same | |
| HK1259871A1 (en) | α-GEL FORMATION COMPOSITION AND α-GEL COMPOSITION | |
| HK1259898A1 (en) | RIPPLE-PHASE-CONTAINING COMPOSITION, α-GEL FORMATION COMPOSITION, EXTERNAL SKIN CARE COMPOSITION USING α-GEL FORMATION COMPOSITION, AND α-GEL COMPOSITION USING α-GEL FORMATION COMPOSITION | |
| HK1227318A1 (en) | Oil-in-water type emulsion composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180313 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180511 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20181002 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20181025 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6426635 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |